{
  "meta": {
    "title": "00044_Late_Night_Pyq_Pyt_Marathon_-_44",
    "url": "https://brainandscalpel.vercel.app/00044-late-night-pyq-pyt-marathon-44-5e58eb77.html",
    "scrapedAt": "2025-11-29T17:24:52.348Z"
  },
  "questions": [
    {
      "id": 11122,
      "choices": [
        {
          "id": 44454,
          "text": "<p><span style=\"font-size:18px;\">Not rejecting a null hypothesis when it is true</span></p>"
        },
        {
          "id": 44455,
          "text": "<p><span style=\"font-size:18px;\">Rejecting a null hypothesis when it is true</span></p>"
        },
        {
          "id": 44456,
          "text": "<p><span style=\"font-size:18px;\">Not rejecting a null hypothesis when it is false</span></p>"
        },
        {
          "id": 44457,
          "text": "<p><span style=\"font-size:18px;\">Rejecting a null hypothesis when it is false</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A researcher is analyzing the results of a study comparing two antihypertensive drugs in an Indian population. She comes across the term \"p-value\" in her statistical analyses. Which of the following best describes the interpretation of a p-value with regard to the probability related to the null hypothesis? </strong><i><strong>[AIIMS NOV 2017]</strong></i></span></p>",
      "unique_key": "Q2377881",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147291,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Rejecting a null hypothesis when it is true</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The p-value represents the likelihood of mistakenly rejecting a true null hypothesis. It serves as the threshold for determining statistical significance.</span></li><li><span style=\"font-size:18px;\">In essence, the p-value signifies the probability of erroneously rejecting a valid null hypothesis, leading to a Type I error.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Not rejecting a null hypothesis when it is true:</strong> This describes a correct decision where the null hypothesis is true, and the researcher correctly decides not to reject it. This scenario does not involve a p-value interpretation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Not rejecting a null hypothesis when it is false:</strong> This describes a Type II error, where the null hypothesis is false, but the researcher fails to reject it. The p-value is not directly related to this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Rejecting a null hypothesis when it is false:</strong> This describes a correct decision where the null hypothesis is false, and the researcher correctly rejects it. This is the goal of hypothesis testing but not the specific interpretation of a p-value.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Null Hypothesis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Hypothesis (H): Is an assumption about the status of a phenomenon</span></li><li><span style=\"font-size:18px;\">Null Hypothesis (H0): In Biostatistics, when we have to prove a particular hypothesis about difference between 2 regimens, we make Null Hypothesis (For examples, If we have to prove that new treatment is better than older treatment, H0 = new treatment is not better than older treatment).</span></li></ul>",
      "correct_choice_id": 44455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20349,
      "choices": [
        {
          "id": 81357,
          "text": "<p><span style=\"font-size:18px;\">Green</span></p>"
        },
        {
          "id": 81358,
          "text": "<p><span style=\"font-size:18px;\">Red</span></p>"
        },
        {
          "id": 81359,
          "text": "<p><span style=\"font-size:18px;\">Grey</span></p>"
        },
        {
          "id": 81360,
          "text": "<p><span style=\"font-size:18px;\">Yellow</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A 22-year-old female comes to the STI clinic with minimal vaginal discharge. On speculum examination, erosions are seen on the cervix. Which of the following kit should be given to this patient? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
      "unique_key": "Q1668333",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147292,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Grey</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The patient presents with erosions on the cervix, which is indicative of cervicitis. According to the syndromic management guidelines for sexually transmitted infections (STIs), cervicitis is treated with the Grey Kit (Kit 1).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>STI color coded kits:&nbsp;</strong></span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-095220.png\" alt=\"\" width=\"1000\" height=\"349\"></span></p>",
      "correct_choice_id": 81359,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54758,
      "choices": [
        {
          "id": 218497,
          "text": "<p><span style=\"font-size:18px;\">Subunit vaccine</span></p>"
        },
        {
          "id": 218498,
          "text": "<p><span style=\"font-size:18px;\">Not given after 6 months of age</span></p>"
        },
        {
          "id": 218499,
          "text": "<p><span style=\"font-size:18px;\">Oral route of administration</span></p>"
        },
        {
          "id": 218500,
          "text": "<p><span style=\"font-size:18px;\">Given as monovalent and pentavalent vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>All are true about Rotaviral vaccine except:&nbsp;[</strong><i><strong>INICET MAY 2024]</strong></i></span></p>",
      "unique_key": "Q8949728",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147293,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Not given after 6 months of age</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Rotaviral vaccine is included in the National Immunization Schedule of India and is primarily available in two types: <strong>Rotavac and Rotasil</strong>.</span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/26/screenshot-2024-08-26-100500.png\" alt=\"\" width=\"1000\" height=\"369\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Note -</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The vaccine is typically given at 6, 10, and 14 weeks of age under NIS, with the possibility of extending the schedule <strong>up to 12 months in cases of delayed immunization</strong>.</span></li><li><span style=\"font-size:18px;\">Both vaccines are live attenuated, but VP8 subunit vaccine is also available, offering more strain specificity and showing good results in infants, adolescents, and adults.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">However, it is incorrect to state that the vaccine is \"Not given after 6 months of age,\" as it can be administered up to 12 months of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Subunit vaccine</strong>: This statement is true as there is a subunit vaccine for rotavirus, specifically the VP8 subunit V protein vaccine, which has shown good results in various age groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Oral route of administration</strong>: This is correct. Rotaviral vaccines are given orally.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Given as monovalent and pentavalent vaccine</strong>: This is also correct. Rotavac is a monovalent vaccine, and Rotasil is a pentavalent vaccine.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Rotaviral vaccine can be given up to 12 months of age according to the National Immunization Schedule of India.</span></p>",
      "correct_choice_id": 218498,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11033,
      "choices": [
        {
          "id": 44098,
          "text": "<p><span style=\"font-size:18px;\">Not more than 10% of the people benefitted by the drug could be due to chance</span></p>"
        },
        {
          "id": 44099,
          "text": "<p><span style=\"font-size:18px;\">90% of patients will be benefitted by giving the drug</span></p>"
        },
        {
          "id": 44100,
          "text": "<p><span style=\"font-size:18px;\">The test is 90% reproducible</span></p>"
        },
        {
          "id": 44101,
          "text": "<p><span style=\"font-size:18px;\">90% of test results could have occurred by chance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>An investigative study was conducted in Mumbai wherein a promising new antihypertensive medication was evaluated for its potential efficacy. Initial clinical trials with a diverse cohort of patients with chronic hypertension revealed promising results in managing elevated blood pressure levels. The efficacy of the drug was measured meticulously, and upon analyzing the data, a p-value of &lt; 0.10 was documented. Given this statistical information and considering the nuances of research interpretation, which of the following statements best elucidates the implications of this p-value in terms of the drug's effect? </strong><i><strong>[AIIMS MAY 2017]</strong></i></span></p>",
      "unique_key": "Q1823901",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147294,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Not more than 10% of the people benefitted by the drug could be due to chance</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">A P-value of less than 0.10 suggests that the likelihood of the drug's benefits occurring due to chance is no higher than 10%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>&nbsp;INTERPRETATION:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Out of 100 repeated tests, a statistically insignificant difference will occur only 10 times, while a statistically significant difference will emerge 90 times.</span></li><li><span style=\"font-size:18px;\">There is a 10% probability of incorrectly concluding that a drug is beneficial when it is not, which can happen in statistical studies when deciding whether to accept or reject a null hypothesis.</span></li><li><span style=\"font-size:18px;\">The P value is compared to a predetermined threshold value 'a'; if the P value is less than 'a', the test is considered statistically significant, and the null hypothesis is rejected.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The p-value is a statistical parameter used to evaluate whether the results of an experiment are statistically significant.</span></li><li><span style=\"font-size:18px;\">In this case, a p-value of &lt; 0.10 suggests there is up to a 10% chance that the observed benefits from the antihypertensive drug could be due to random variation rather than a true effect of the drug.</span></li></ul>",
      "correct_choice_id": 44098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10253,
      "choices": [
        {
          "id": 40978,
          "text": "<p><span style=\"font-size:18px;\">Therapeutic assessment</span></p>"
        },
        {
          "id": 40979,
          "text": "<p><span style=\"font-size:18px;\">Physical assessment</span></p>"
        },
        {
          "id": 40980,
          "text": "<p><span style=\"font-size:18px;\">Biochemical assessment</span></p>"
        },
        {
          "id": 40981,
          "text": "<p><span style=\"font-size:18px;\">Behavioral assessment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Which of the following steps is not included in WHO's STEP approach?</strong><i><strong>[NEET &nbsp;PG 2022]</strong></i></span></p>",
      "unique_key": "Q9476006",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147295,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Therapeutic assessment</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">STEPwise approach to surveillance (STEPS) is a simple, standardized method by WHO for surveillance. It is of two types:</span><ul><li><span style=\"font-size:18px;\">STEPwise approach to chronic disease risk factor surveillance</span></li><li><span style=\"font-size:18px;\">STEPwise approach to Stroke surveillance</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/04/screenshot-2023-10-04-121523.jpg\" alt=\"\" width=\"800\" height=\"453\"></span></p>",
      "correct_choice_id": 40978,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59788,
      "choices": [
        {
          "id": 238453,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Analysis of variance&nbsp;</span></span></span></p>"
        },
        {
          "id": 238454,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Pearson coefficient&nbsp;</span></span></span></p>"
        },
        {
          "id": 238455,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Receiver-operating characteristic curve&nbsp;</span></span></span></p>"
        },
        {
          "id": 238456,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre-test probability</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Which of the following statistical tools is most suitable for establishing the optimal cutoff point to distinguish between positive and negative test results? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q2605536",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147296,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. Receiver-operating characteristic curve</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture1_AY5w047.jpg\" style=\"height:261px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Receiver-operating characteristic (ROC) curve:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> An ROC curve plots the true positive rate (sensitivity) against the false positive rate (1-specificity) for different test result cut-off points. It allows for the visualization of the trade-off between sensitivity and specificity at various thresholds. The optimal threshold is often chosen based on the point on the curve closest to the top-left corner (maximizing true positives while minimizing false positives) or by considering the specific clinical context and the relative importance of sensitivity and specificity.&nbsp;&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Analysis of variance (ANOVA):</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> ANOVA is used to compare means between three or more groups. It is not relevant to determining the diagnostic threshold for a test.&nbsp;&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. Pearson coefficient:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> The Pearson correlation coefficient measures the linear relationship between two continuous variables. It does not directly help in setting the threshold for a diagnostic test.&nbsp;&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Pre-test probability:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This is the estimated likelihood of a patient having the condition before the test is conducted. While it can influence the interpretation of test results, it doesn&#39;t help in determining the optimal threshold itself.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The ROC curve is the most appropriate tool for determining the optimal threshold for a diagnostic test, as it allows for the visualization and balancing of sensitivity and specificity at different cutoff points.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 238455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24754,
      "choices": [
        {
          "id": 98977,
          "text": "<p><span style=\"font-size:18px;\">Unequal precision band</span></p>"
        },
        {
          "id": 98978,
          "text": "<p><span style=\"font-size:18px;\">Hirshberg band</span></p>"
        },
        {
          "id": 98979,
          "text": "<p><span style=\"font-size:18px;\">Holmes band</span></p>"
        },
        {
          "id": 98980,
          "text": "<p><span style=\"font-size:18px;\">Hall-Wellner Band</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>What among the following can be employed for establishing the confidence interval in the Kaplan-Meier survival curve?</strong><i><strong> [INICET MAY 2023]</strong></i></span></p>",
      "unique_key": "Q2033263",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147297,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Hall-Wellner Band</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Kaplan-Meier survival curve is a graphical representation commonly used in survival analysis to display the probability of an event, typically survival, over time.</span></li><li><span style=\"font-size:18px;\">It is particularly useful when studying the time to a specific event, such as death or disease progression.</span></li><li><span style=\"font-size:18px;\">The Kaplan-Meier curve often incorporates bands around the survival estimate, which represent the confidence interval.</span></li><li><span style=\"font-size:18px;\">Hall-Wellner bands, Gill bands, and Nair's Equal Precision confidence bands are used for this purpose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/psm.jpg\" alt=\"\" width=\"400\" height=\"361\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Unequal precision band:</strong> Not a standard term used for Kaplan-Meier survival curves.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Hirshberg band:</strong> Not a recognized method for establishing confidence intervals in Kaplan-Meier survival curves.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Holmes band:</strong> Not a recognized method for establishing confidence intervals in Kaplan-Meier survival curves.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Hall-Wellner band is employed for establishing the confidence interval in the Kaplan-Meier survival curve, providing a visual representation of the variability and confidence in the survival estimates.</span></li></ul>",
      "correct_choice_id": 98980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11055,
      "choices": [
        {
          "id": 44186,
          "text": "<p><span style=\"font-size:18px;\">3 &gt;2&gt;1</span></p>"
        },
        {
          "id": 44187,
          "text": "<p><span style=\"font-size:18px;\">3&gt;1&gt;2</span></p>"
        },
        {
          "id": 44188,
          "text": "<p><span style=\"font-size:18px;\">1&gt;2&gt;3</span></p>"
        },
        {
          "id": 44189,
          "text": "<p><span style=\"font-size:18px;\">1=2=3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>As a medical student, you're learning about the margin of error and its relationship with sample size. With three studies of different sizes (Sample 1: 1000, Sample 2: 800, Sample 3: 600), how would you order the expected margins of error from largest to smallest? </strong><i><strong>[AIIMS MAY 2018]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip8.jpg\" alt=\"\" width=\"572\" height=\"333\"></strong></span></p>",
      "unique_key": "Q2081991",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147298,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) 3&gt;2&gt;1</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Curve 1 exhibits the smallest margin of error, followed by Curve 2, and then Curve 3. Thus, the ranking is as follows: 3&gt;2&gt;1.</span></li><li><span style=\"font-size:18px;\">The depicted image showcases three normal distribution curves with varying sample sizes, all sharing the same mean but differing in standard deviation.</span></li><li><span style=\"font-size:18px;\">When the sample size decreases, the peak diminishes, and the curve adopts a flatter shape.</span></li><li><span style=\"font-size:18px;\">This signifies a broader confidence interval for the specified mean.</span></li><li><span style=\"font-size:18px;\">The width of the curve's base is directly linked to the margin of error.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The margin of error in a study is inversely related to the square root of the sample size.</span></li><li><span style=\"font-size:18px;\">This relationship implies that a larger sample size will generally lead to a smaller margin of error, assuming other variables like variance remain constant.</span></li></ul>",
      "correct_choice_id": 44186,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49026,
      "choices": [
        {
          "id": 195679,
          "text": "<p><span style=\"font-size:18px;\">To cure disease</span></p>"
        },
        {
          "id": 195680,
          "text": "<p><span style=\"font-size:18px;\">Do nothing to prolong life</span></p>"
        },
        {
          "id": 195681,
          "text": "<p><span style=\"font-size:18px;\">To improve quality of life patient</span></p>"
        },
        {
          "id": 195682,
          "text": "<p><span style=\"font-size:18px;\">Nothing is done in palliative care</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 68-year-old male with a history of stage IV non-small cell lung cancer presents with worsening dyspnea, non-productive cough, and uncontrolled pain despite current medication. He has declined further aggressive treatment. What stands true for Palliative care?&nbsp;</strong><i><strong>[INICET NOV 2023]</strong></i></span></p>",
      "unique_key": "Q5630137",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147299,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) To improve quality of life patient</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Palliative care is a specialized medical care focused on providing relief from the symptoms and stress of a serious illness.</span></li><li><span style=\"font-size:18px;\">The primary goal of palliative care is <strong>to improve the quality of life for the patient</strong>.&nbsp;</span></li><li><span style=\"font-size:18px;\">It involves treating pain and other distressing symptoms, providing psychological and spiritual care, and supporting the patient and their family to cope with the challenges of a serious illness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. To cure disease</strong>: This is incorrect. Palliative care does not aim to cure the underlying disease but focuses on alleviating symptoms and improving the quality of life for both the patient and their family.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Do nothing to prolong life</strong>: Palliative care does not necessarily aim to prolong life, nor does it hasten death. It’s about enhancing the quality of life and may also indirectly prolong it by improving general health and well-being.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Nothing is done in palliative care</strong>: This is incorrect. Palliative care involves active and comprehensive management of various issues that arise with serious illnesses, including physical, emotional, social, and spiritual aspects of care.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Palliative care is crucial for improving the quality of life for patients with serious illnesses.&nbsp;</span></li><li><span style=\"font-size:18px;\">It addresses a wide range of needs, ensuring the patient’s comfort and supporting the family through difficult times, emphasizing symptom management and personal support over curative treatments.</span></li></ul>",
      "correct_choice_id": 195681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59790,
      "choices": [
        {
          "id": 238461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">National Maternity Benefit Scheme (NMBS)</span></span></span></p>"
        },
        {
          "id": 238462,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Janani Shishu Suraksha Karyakram (JSSK)</span></span></span></p>"
        },
        {
          "id": 238463,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rashtriya Bal Swasthya Karyakram (RBSK)</span></span></span></p>"
        },
        {
          "id": 238464,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Integrated Child Development Services (ICDS)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 32-year-old woman delivers her baby in a public hospital in a rural district in India. She is informed by the healthcare provider that she will receive free transportation, medications, and diet during her hospital stay for both herself and her newborn. The provider further explains that this is part of a program introduced in 2011 under the National Rural Health Mission (NRHM) to ensure better health outcomes for mothers and newborns by expanding the scope of an earlier program, which initially focused only on maternal health. Which of the following programs is most likely being referred to?</span></span></span></p>",
      "unique_key": "Q3465540",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147300,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) Janani Shishu Suraksha Karyakram (JSSK)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>Janani Shishu Suraksha Karyakram (JSSK)</strong>, launched on June 1, 2011, under the National Rural Health Mission (NRHM), provides free and cashless services to pregnant women and their newborns, including free transport, medications, and diet. JSSK was introduced as an extension of the <strong>Janani Suraksha Yojana (JSY)</strong>, which originally focused only on maternal health. JSSK expanded the scope to include newborn care up to 1 year of age, recognizing the need for comprehensive care for both mothers and infants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) National Maternity Benefit Scheme (NMBS):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This program was the predecessor to the <strong>Janani Suraksha Yojana (JSY)</strong>. While NMBS provided financial assistance to pregnant women, it did not offer the broad range of free services that JSSK provides for both mothers and newborns.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C) Rashtriya Bal Swasthya Karyakram (RBSK):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> RBSK is a child health program that focuses on early identification and management of health conditions in children up to 18 years of age. It is not designed specifically for maternal and newborn care.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Integrated Child Development Services (ICDS):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> ICDS focuses on improving the nutrition and health of children up to 6 years of age, as well as pregnant and lactating mothers, but it does not provide free medical services for deliveries like JSSK.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>Janani Shishu Suraksha Karyakram (JSSK)</strong> provides free and cashless healthcare services to pregnant women and newborns in public health facilities, including transportation, medications, and diet. It was introduced in 2011 to extend the focus of the <strong>Janani Suraksha Yojana (JSY)</strong>, which was initially aimed only at maternal health.</span></span></span></p>",
      "correct_choice_id": 238462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11082,
      "choices": [
        {
          "id": 44294,
          "text": "<p><span style=\"font-size:18px;\">Tuberculosis</span></p>"
        },
        {
          "id": 44295,
          "text": "<p><span style=\"font-size:18px;\">Herpes Zoster</span></p>"
        },
        {
          "id": 44296,
          "text": "<p><span style=\"font-size:18px;\">Measles</span></p>"
        },
        {
          "id": 44297,
          "text": "<p><span style=\"font-size:18px;\">Chicken Pox</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 40-year-old nurse in the infectious diseases ward is reviewing the necessary precautions for attending to patients with various primary diagnoses. For which of the following patients would she NOT need to take special airborne precautions? </strong><i><strong>[AIIMS MAY 2020]</strong></i></span></p>",
      "unique_key": "Q2537977",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147301,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Herpes Zoster&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">While Herpes Zoster (shingles) can be contagious, it primarily requires contact precautions unless disseminated or in the immunocompromised, where it might necessitate airborne precautions if there are pulmonary symptoms.</span></li><li><span style=\"font-size:18px;\">Generally, for localized shingles in an immunocompetent patient, standard precautions along with contact precautions are sufficient, thus not routinely requiring airborne precautions like the diseases listed in the other options.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Tuberculosis:</strong> Requires airborne precautions due to the high risk of transmission through airborne particles, particularly the respiratory droplets that can suspend in the air for extended periods.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Measles:</strong> Highly contagious and spreads through airborne transmission. Airborne precautions are essential due to measles' ability to remain airborne for up to two hours after the infected person has left the area.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Chicken Pox (Varicella):</strong> Also spread through airborne transmission, requiring similar precautions to measles to prevent the spread of the virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Measles, Tuberculosis, and chickenpox require airborne transmission precaution unlike herpes zoster.</span></li><li><span style=\"font-size:18px;\">The patient should be made to wear a mask for source control.</span></li><li><span style=\"font-size:18px;\">A fit-tested NIOSH-approved N95 or higher-level respirator should be used by the healthcare personnel whilst care delivery.</span></li></ul>",
      "correct_choice_id": 44295,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10164,
      "choices": [
        {
          "id": 40622,
          "text": "<p><span style=\"font-size:18px;\">Specific protection</span></p>"
        },
        {
          "id": 40623,
          "text": "<p><span style=\"font-size:18px;\">Early diagnosis and treatment</span></p>"
        },
        {
          "id": 40624,
          "text": "<p><span style=\"font-size:18px;\">Disability limitation</span></p>"
        },
        {
          "id": 40625,
          "text": "<p><span style=\"font-size:18px;\">Rehabilitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Which of the following is the best level of prevention of breast cancer? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
      "unique_key": "Q7161214",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147302,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Early diagnosis and treatment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Early diagnosis and treatment are crucial in the management of breast cancer. This involves screening methods such as mammography, which can detect cancer at an early stage when it is more likely to be treated successfully. Early treatment can significantly improve survival rates and outcomes for patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Specific protection:&nbsp;</strong>Specific protection involves preventive measures that protect against specific diseases, such as vaccinations or using protective equipment. Currently, there is no vaccine or specific protective measure that can prevent breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Disability limitation:&nbsp;</strong>Disability limitation is part of tertiary prevention and focuses on minimizing the impact of an ongoing illness that has already caused some level of disability. It involves strategies to prevent complications and further disability. This is more applicable after a disease has been diagnosed and is not the best level of prevention for breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Rehabilitation:&nbsp;</strong>Rehabilitation is also a part of tertiary prevention and aims to help individuals recover as much function as possible after a disease has caused disability. It includes therapies to restore physical, psychological, and social functioning. While important, it is not the best preventive strategy for breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Early diagnosis and treatment (secondary prevention) are the most effective methods for preventing the progression of breast cancer, as they allow for early detection and intervention, significantly improving the chances of successful treatment and reducing mortality rates.</span></p>",
      "correct_choice_id": 40623,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11107,
      "choices": [
        {
          "id": 44394,
          "text": "<p><span style=\"font-size:18px;\">Collect using your hand and discard in drain</span></p>"
        },
        {
          "id": 44395,
          "text": "<p><span style=\"font-size:18px;\">Collect using paper/cardboard and put in water tube/bucket</span></p>"
        },
        {
          "id": 44396,
          "text": "<p><span style=\"font-size:18px;\">Collect and throw outside in the environment</span></p>"
        },
        {
          "id": 44397,
          "text": "<p><span style=\"font-size:18px;\">Broom it and discard in dustbin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A medical student accidentally drops a sphygmomanometer, causing mercury spill on the floor. What is the most appropriate method to manage this spill? </strong><i><strong>[INICET MAY 2022]</strong></i></span></p>",
      "unique_key": "Q3787518",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147303,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Collect using paper/cardboard and put in water tube/bucket</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Identify visible larger mercury beads and push together using Cardboards and collect using Syringe without needle.</span></li><li><span style=\"font-size:18px;\">Store collected mercury beads in an air tight plastic bag and label it properly. Put all the items that were used to pick up the mercury, including index cards or cardboard, eyedropper, contaminated tape, paper towels, and zipper-type bags into the trash bag. Carefully seal the trash bag that contains the mercury contaminated waste and dispose them properly.</span></li><li><span style=\"font-size:18px;\">Do not use a vacuum, broom or paint brush to clean up the spill. These methods can spread the mercury to other areas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The most appropriate method to manage a mercury spill is to collect it using paper/cardboard and place it in a water tube or bucket, then ensure safe and proper disposal.</span></li><li><span style=\"font-size:18px;\">Avoid direct contact, vacuuming, or sweeping the mercury.</span></li></ul>",
      "correct_choice_id": 44395,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11135,
      "choices": [
        {
          "id": 44506,
          "text": "<p><span style=\"font-size:18px;\">Cytotoxic waste</span></p>"
        },
        {
          "id": 44507,
          "text": "<p><span style=\"font-size:18px;\">Biomedical waste</span></p>"
        },
        {
          "id": 44508,
          "text": "<p><span style=\"font-size:18px;\">Radiation hazard</span></p>"
        },
        {
          "id": 44509,
          "text": "<p><span style=\"font-size:18px;\">Biohazard</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Based on the emblem as shown below, which of the following best describes the warning it signifies? </strong><i><strong>[AIIMS NOV 2018]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip37.jpg\" alt=\"\" width=\"300\" height=\"302\"></strong></span></p>",
      "unique_key": "Q7675897",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147304,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Radiation hazard</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>INTERNATIONAL RADIATION SYMBOL (TREFOIL)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Central circle of radius R, an internal radius of 1.5R and an external radius of 5R for the blades, which are separated from each other by 60°</span></li><li><span style=\"font-size:18px;\">Trefoil is black in the international version</span></li><li><span style=\"font-size:18px;\">Commonly referred to as a Radioactivity warning sign, but it is actually a warning sign of ionizing radiation</span></li><li><span style=\"font-size:18px;\">Includes X-ray apparatus, medical beam cannons and particle accelerators.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Cytotoxic waste:</strong> This waste includes materials that are toxic to cells, such as chemotherapy waste, but uses a different symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Biomedical waste:</strong> This refers to waste generated from medical procedures, often marked with a biohazard symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Biohazard:</strong> Indicates the presence of biological substances that pose a threat to human health, marked with a different symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip38.jpg\" alt=\"\" width=\"700\" height=\"243\"></span></p>",
      "correct_choice_id": 44508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11189,
      "choices": [
        {
          "id": 44722,
          "text": "<p><span style=\"font-size:18px;\">Disaster response</span></p>"
        },
        {
          "id": 44723,
          "text": "<p><span style=\"font-size:18px;\">Disaster reconstruction</span></p>"
        },
        {
          "id": 44724,
          "text": "<p><span style=\"font-size:18px;\">Disaster rehabilitation</span></p>"
        },
        {
          "id": 44725,
          "text": "<p><span style=\"font-size:18px;\">Disaster mitigation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 38-year-old civil engineer is working on a construction project in an area recently affected by a devastating earthquake. To prevent future devastation, the local government has amended the building codes. These changes are aimed at ensuring structures in the area can better withstand seismic activity. The engineer reviews the changes to determine the best approach for the new construction project. This modification to the building codes is primarily an example of which phase of disaster management? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p>",
      "unique_key": "Q7758821",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147505,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Disaster mitigation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The measures that are taken to prevent disasters from causing emergencies or to lessen the likely effects of emergencies are part of disaster mitigation.</span></li><li><span style=\"font-size:18px;\">Mitigation involves measures designed either to prevent hazards from causing an emergency or to lessen the likely effects of emergencies. In most cases mitigation measures aim to reduce the vulnerability of the system.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">In Disaster Cycle, the steps involved are –</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Disaster Impact and Response:&nbsp;</strong>it involves search, rescue, first aid of the patients, triaging them according to the severity of their injuries and their likelihood of survival with prompt medical intervention, tagging and identification of dead.</span></li><li><span style=\"font-size:18px;\"><strong>Relief Phase or Disaster Containment&nbsp;</strong>by prompt assistance, epidemiological surveillance and disease control, vaccination, nutritional support.</span></li><li><span style=\"font-size:18px;\"><strong>Rehabilitation&nbsp;</strong>involves restoration of the pre-disaster conditions. It takes into account assessment and restoration of water supply, food safety and supply, basic sanitation, personal hygiene, vector control.</span></li><li><span style=\"font-size:18px;\"><strong>Disaster Mitigation&nbsp;</strong>involves<strong> </strong>measures<strong> </strong>aimed at reducing or preventing the hazards from causing any emergency or to dampen the effects of emergencies. It involves flood mitigation works, appropriate land-use planning, improved building codes and reduction or protection of vulnerable population and structures.</span></li><li><span style=\"font-size:18px;\"><strong>Disaster Preparedness&nbsp;</strong>is a long-term programme of developmental activities which aims at strengthening the overall capacity and capability of the country to efficiently and effectively manage all the emergencies.<strong>&nbsp;</strong>&nbsp;</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:18px;\">&nbsp;&nbsp;&nbsp; <img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/whatsapp-image-2023-10-20-at-173957.jpeg\" alt=\"\" width=\"500\" height=\"534\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Disaster mitigation involves proactive measures such as improved building codes to reduce the impact of future disasters, aiming to lessen vulnerability and enhance resilience against potential hazards.</span></li></ul>",
      "correct_choice_id": 44725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10227,
      "choices": [
        {
          "id": 40874,
          "text": "<p><span style=\"font-size:18px;\">Xenopsylla cheopis</span></p>"
        },
        {
          "id": 40875,
          "text": "<p><span style=\"font-size:18px;\">Phlebotomus argentipes</span></p>"
        },
        {
          "id": 40876,
          "text": "<p><span style=\"font-size:18px;\">Ixodes tick</span></p>"
        },
        {
          "id": 40877,
          "text": "<p><span style=\"font-size:18px;\">Female Anopheles mosquito</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A bubonic outbreak has occurred within the community. What is the responsible vector for this condition?</strong><i><strong> [NEET PG 2021]</strong></i></span></p>",
      "unique_key": "Q6783627",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147506,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Xenopsylla cheopis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Xenopsylla cheopis, commonly known as a rat flea, serves as the carrier for the bubonic plague. This particular flea species can be recognized by its distinctive conical-shaped head, along with a thorax, abdomen, and three sets of legs.</span></p><p style=\"text-align:justify;\"><br><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/70.jpg\" alt=\"\" width=\"400\" height=\"273\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:18px;\">Plague is a zoonotic disease caused by Yersinia pestis.</span></li><li><span style=\"font-size:18px;\">The reservoir of infections is wild rodents.</span></li><li><span style=\"font-size:18px;\">Humans acquire the disease by the bite of an infected flea, by direct contact with the tissues of the infected animal, or by droplet infection from cases of pneumonic plague.</span></li><li><span style=\"font-size:18px;\">Human plague mainly presents as:</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><i>Bubonic plague</i>- This is the most common type of disease. There is fever along with painful lymphadenitis. Within a few days, the lymph nodes in the groin, axilla, or neck enlarge and are called buboes. This is followed by the suppuration of the buboes.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><i>Pneumonic plague</i>- It develops as a complication of bubonic-septicemic plague.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><i>Septicemic plague</i>- It occurs when the infection spreads to blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.&nbsp;Species</strong> <strong>Phlebotomus argentipes</strong>: belongs to the group of sand fly. It transmits kala azar. Other diseases transmitted by sand flies are sandfly fever and oriental sore.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.&nbsp;Ixodes Tick</strong>: transmits Lyme’s disease caused by Borrelia burgdorferi.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.&nbsp;Female Anopheles mosquito</strong> transmits malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Xenopsylla cheopis (rat flea) is the primary vector responsible for transmitting the bubonic plague, caused by Yersinia pestis. Understanding the vector and transmission routes is crucial for controlling and preventing outbreaks.</span></p>",
      "correct_choice_id": 40874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11093,
      "choices": [
        {
          "id": 44338,
          "text": "<p><span style=\"font-size:18px;\">1000, rf= 3</span></p>"
        },
        {
          "id": 44339,
          "text": "<p><span style=\"font-size:18px;\">1200, rf=2</span></p>"
        },
        {
          "id": 44340,
          "text": "<p><span style=\"font-size:18px;\">1600, rf= 3</span></p>"
        },
        {
          "id": 44341,
          "text": "<p><span style=\"font-size:18px;\">3000, rf= 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>At the Urban Primary Health Centre (U-PHC), you are in charge of managing hypertension clinic services. You have 50 patients transferred from another healthcare unit for hypertension management; 40 of these patients are prescribed amlodipine (5mg, daily) and 10 are on lisinopril (10mg, daily) due to contraindications with amlodipine. Considering the need for continuous treatment and potential increases in patient numbers, calculate the number of tablets needed for the next month and determine the appropriate reorder factor. [</strong><i><strong>INICET MAY 2021]</strong></i></span></p>",
      "unique_key": "Q9744907",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147507,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) 3000, rf=2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Calculation -&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Requirement of Amlodipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">40 patients x 1 Tablet per day x 30 Days = <strong>1200</strong> Tablets</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Requirement of Lisinopril</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">10 patients x 1 Tablet per day x 30 Days = <strong>300</strong> Tablets</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Reorder factor (Rf) for drugs supplied every:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">1 Month - 2</span></li><li><span style=\"font-size:18px;\">3 Months - 6</span></li><li><span style=\"font-size:18px;\">6 Months – 12</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>For the given question,</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total of 1500 tablets are required and reorder factor is 2</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hence, Total tablets required = (1200 + 300) x 2 = 3000 Tablets</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Reorder Factor (rf):&nbsp;</strong>A reorder factor of 2 is commonly used for monthly resupply scenarios to account for unexpected increases in patient count or dosage adjustments, ensuring no interruption in patient care.</span></li></ul>",
      "correct_choice_id": 44341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11071,
      "choices": [
        {
          "id": 44250,
          "text": "<p><span style=\"font-size:18px;\">Strength of correlation is same in A and B</span></p>"
        },
        {
          "id": 44251,
          "text": "<p><span style=\"font-size:18px;\">Strength of the correlation is more in A than in B</span></p>"
        },
        {
          "id": 44252,
          "text": "<p><span style=\"font-size:18px;\">Strength of the variation is more in B than A</span></p>"
        },
        {
          "id": 44253,
          "text": "<p><span style=\"font-size:18px;\">Variation in variables is more with A than B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A perinatologist is analyzing scatterplots from two research studies on the relationship between bone marrow density and gestational age. Study A shows data points tightly clustered along a trend line, while Study B shows data points that are more spread out but still follow a general trend line. Which statement correctly describes the relationship between bone marrow density and gestational age based on these observations? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip12.jpg\" alt=\"\" width=\"200\" height=\"450\"></strong></span></p>",
      "unique_key": "Q9684976",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147508,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Strength of the correlation is more in A than in B</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Graph A represents stronger correlation than graph B.</span></li><li><span style=\"font-size:18px;\">More compact and close the dots are to the line, stronger is the relation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture11_Zx8B4xH.jpg\" alt=\"\" width=\"700\" height=\"254\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124648.jpg\" alt=\"\" width=\"1000\" height=\"664\"></span></p>",
      "correct_choice_id": 44251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11179,
      "choices": [
        {
          "id": 44682,
          "text": "<p><span style=\"font-size:18px;\">Follow up</span></p>"
        },
        {
          "id": 44683,
          "text": "<p><span style=\"font-size:18px;\">Matching</span></p>"
        },
        {
          "id": 44684,
          "text": "<p><span style=\"font-size:18px;\">Strength of association</span></p>"
        },
        {
          "id": 44685,
          "text": "<p><span style=\"font-size:18px;\">Selection of study subjects</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>You're mentoring a group of budding epidemiologists who are keen on understanding the nuances of different study designs. One of them is particularly interested in case-control studies. During your discussion, you decide to quiz them on aspects that are typically not inherent to case-control studies. Which of the given options would not usually be part of a case-control study? </strong><i><strong>[INICET NOV 2021]</strong></i></span></p>",
      "unique_key": "Q2147779",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147509,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Follow up&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Follow up is not a component of case-control studies.</span></li><li><span style=\"font-size:18px;\">These studies are retrospective and do not involve tracking subjects over time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Matching:</strong> Process of selecting controls in a such a way that they are similar to cases (with regard to certain pertinent selected variables which may influence the outcome of disease, thereby distorting the results). It eliminates confounding.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Strength of association:</strong> In case-control studies, the strength of association is measured using the odds ratio (an estimate of relative risk).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Selection of study subjects:</strong> Essential in case-control studies, involving the selection of cases with the disease and controls without the disease.</span></p><p>&nbsp;</p><h3><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></h3><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Case-control studies do not include follow-up of subjects but focus on matching, assessing the strength of association using odds ratios, and selecting cases and controls for analysis.</span></li></ul>",
      "correct_choice_id": 44682,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59791,
      "choices": [
        {
          "id": 238465,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemometer</span></span></span></p>"
        },
        {
          "id": 238466,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kata thermometer</span></span></span></p>"
        },
        {
          "id": 238467,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Barometer</span></span></span></p>"
        },
        {
          "id": 238468,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hygrometer</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A researcher is conducting an experiment in a controlled climate room to measure the air velocity. To assess the cooling effect of the air, the researcher uses an instrument that cools based on the surrounding air movement. What is the name of this instrument, as shown below?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture2_AfTgjIM.jpg\" style=\"height:78px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q3557024",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147510,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Answer: B) Kata thermometer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>Kata thermometer</strong> is an instrument traditionally used to measure the cooling power of air, particularly in moving air environments. It works by measuring how quickly it cools down when exposed to airflow. In modern times, the Kata thermometer is more commonly used to assess low air velocity, determining the rate of heat loss in still air. It is particularly useful in controlled climates or laboratory conditions for evaluating air movement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) Anemometer:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> An anemometer is used to measure wind speed or air velocity, typically in outdoor environments, but it does not measure cooling effects like the Kata thermometer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Barometer:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A barometer measures atmospheric pressure, not air velocity or cooling power.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) Hygrometer:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A hygrometer is used to measure humidity levels in the air, not the cooling power or air velocity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>Kata thermometer</strong> is used to measure the cooling power of air or low air velocity by determining the rate of heat loss. It is commonly used in laboratories or controlled climate settings.</span></span></span></p>",
      "correct_choice_id": 238466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11148,
      "choices": [
        {
          "id": 44558,
          "text": "<p><span style=\"font-size:18px;\">197</span></p>"
        },
        {
          "id": 44559,
          "text": "<p><span style=\"font-size:18px;\">392</span></p>"
        },
        {
          "id": 44560,
          "text": "<p><span style=\"font-size:18px;\">225</span></p>"
        },
        {
          "id": 44561,
          "text": "<p><span style=\"font-size:18px;\">344</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A community with a population of 20,000 documented 456 births in a year, of which 56 were stillbirths. The total number of deaths in the community for that year was 247, including 56 deaths within the first 28 days of life and 34 additional deaths after 28 days but before completing the first year of life. What is the infant mortality rate (IMR) for this community? </strong><i><strong>[AIIMS NOV 2019]</strong></i></span></p>",
      "unique_key": "Q4668530",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147511,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) 225</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-161612.jpg\" alt=\"\" width=\"500\" height=\"64\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>In the given question,</strong> out of total 456 births, 56 were dead born.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Therefore, the number of live births= 456-56 = 400.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In the same year, it is given that the number of deaths before 28 days is 56, and the number of deaths after 28 days but before 1 year is 34.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hence, the total number of deaths of children &lt; 1 year is 56 + 34 = 90</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">IMR = (90x1000)/400 = 900/4 = 225</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hence, the IMR is 225 per 1000 live births.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>INFANT MORTALITY RATE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">It is the number of deaths per 1000 live births of children under one year of age. It is the most sensitive indicator of availability and utilization of health care services in a country. Is most important indicator of health status of a community, level of living and effectiveness of MCH services in general.&nbsp;</span></li><li><span style=\"font-size:18px;\">IMR is among ‘the best predictors of state failure’</span></li><li><span style=\"font-size:18px;\">It is a rate.</span></li><li><span style=\"font-size:18px;\">IMR of India (2023): 26.6 per 1000 live births;&nbsp;</span></li><li><span style=\"font-size:18px;\">IMR of India - 35 per 1000 live births (NFHS-5 2019-21,);&nbsp;28 per 1000 Live births (SRS, May 2022)</span></li><li><span style=\"font-size:18px;\">Is the second best indicator of socio-economic development of a country: Ultimate solution&nbsp;for lowering IMR lies in socio-economic development [Best indicator is U5MR]</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Infant Mortality Rate (IMR) for the community, calculated as the number of infant deaths per 1000 live births.</span></li><li><span style=\"font-size:18px;\">This rate serves as a crucial indicator of the health status and effectiveness of maternal and child health services in the community.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>NOTE - UNICEF considers U5MR or CMR as ‘single best indicator of socio-economic development and well-being’ (even better than IMR)</strong></span></p>",
      "correct_choice_id": 44560,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11164,
      "choices": [
        {
          "id": 44622,
          "text": "<p><span style=\"font-size:18px;\">Nominal scale data</span></p>"
        },
        {
          "id": 44623,
          "text": "<p><span style=\"font-size:18px;\">Ordinal scale data</span></p>"
        },
        {
          "id": 44624,
          "text": "<p><span style=\"font-size:18px;\">Alphanumerical data</span></p>"
        },
        {
          "id": 44625,
          "text": "<p><span style=\"font-size:18px;\">Interval scale data</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A resident in neurology is assessing a patient who recently sustained a traumatic brain injury using the Glasgow Coma Scale (GCS). How should the resident describe the type of data obtained from the GCS? </strong><i><strong>[INICET NOV 2020]</strong></i></span></p>",
      "unique_key": "Q7336259",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147512,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Ordinal scale data</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Glasgow Coma Scale represents ordinal data since the GCS score is categorized as mild, moderate, or severe, following a specific order of severity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Nominal scale data:</strong> Data based on names without a specific order.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Alphanumerical data:</strong> Data that includes both letters and numbers, not applicable here.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Interval scale data:</strong> Data measured along a scale where each point is equidistant from the next, but GCS does not meet this criterion.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/30/screenshot-2023-10-30-114041.jpg\" alt=\"\" width=\"1000\" height=\"676\"></span></p>",
      "correct_choice_id": 44623,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10197,
      "choices": [
        {
          "id": 40754,
          "text": "<p><span style=\"font-size:18px;\">Mission Dhanush</span></p>"
        },
        {
          "id": 40755,
          "text": "<p><span style=\"font-size:18px;\">Mission Indradhanush</span></p>"
        },
        {
          "id": 40756,
          "text": "<p><span style=\"font-size:18px;\">Mission Suraksha</span></p>"
        },
        {
          "id": 40757,
          "text": "<p><span style=\"font-size:18px;\">Mission Suraksha Yojana</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which of the options was initiated to ensure complete immunization of children? </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
      "unique_key": "Q2552316",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147513,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Mission Indradhanush</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Mission Indradhanush was launched in 2014 by the Ministry of Health and Family Welfare to ensure complete immunization of children who are either partially immunized or completely unimmunized by 2020. Later, it was modified in 2017 as Intensified Mission Indradhanush to achieve the same goal by December 2018, including 12 vaccine-preventable diseases. The program involves 4 rounds of immunization held for 7 days each month, and it replaced the previous focus on 7 diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><u>MISSION INDRADHANUSH INCLUDES</u></strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">Polio</span></li><li><span style=\"font-size:18px;\">Diphtheria</span></li><li><span style=\"font-size:18px;\">Pertussis</span></li><li><span style=\"font-size:18px;\">Tetanus</span></li><li><span style=\"font-size:18px;\">TB</span></li><li><span style=\"font-size:18px;\">Measles</span></li><li><span style=\"font-size:18px;\">Hepatitis B</span></li><li><span style=\"font-size:18px;\">Rota Virus</span></li><li><span style=\"font-size:18px;\">MR</span></li><li><span style=\"font-size:18px;\">IPV</span></li><li><span style=\"font-size:18px;\">JE</span></li><li><span style=\"font-size:18px;\">HiB</span></li><li><span style=\"font-size:18px;\">PCV</span></li></ol>",
      "correct_choice_id": 40755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49028,
      "choices": [
        {
          "id": 195687,
          "text": "<p><span style=\"font-size:18px;\">Custom</span></p>"
        },
        {
          "id": 195688,
          "text": "<p><span style=\"font-size:18px;\">Culture</span></p>"
        },
        {
          "id": 195689,
          "text": "<p><span style=\"font-size:18px;\">Socialization</span></p>"
        },
        {
          "id": 195690,
          "text": "<p><span style=\"font-size:18px;\">Mores</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 25-year-old woman presents to the clinic for a routine check-up. During the social history taking, she mentions that she has started engaging in certain behaviors and rituals that align with her new community after recently moving to a different country. What is the term for this type of behavior acquisition? </strong><i><strong>[INICET NOV 2023]</strong></i></span></p>",
      "unique_key": "Q7014059",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147514,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Socialization</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Learning and try to adapt to new community. This is known as Socialization</span></li><li><span style=\"font-size:18px;\"><strong>Socialization</strong> is the process by which individuals learn and adopt the norms, values, and behaviors appropriate to their society.&nbsp;</span></li><li><span style=\"font-size:18px;\">Socialization is key in helping individuals function as members of their society, and it involves learning the language, norms, and rituals of the community.</span></li><li><span style=\"font-size:18px;\">This term directly applies to the scenario described, as the woman is adopting behaviors that align with her new community.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Custom</strong>: This term refers to a traditional and widely accepted way of behaving or doing something that is specific to a particular society, place, or time. Customs are the established patterns of behavior that can be objectively verified within a particular social setting</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Culture</strong>: Is the learned behavior which is socially acquired. Culture is a broader term that includes knowledge, belief systems, art, morals, laws, and any other capabilities and habits acquired by individuals as members of society.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Mores</strong>: These are the moral norms, manners, or customs that are considered important for the welfare of a community and are enforced by social disapproval or formal sanctions if violated. Mores are a subset of social norms that include strong moral connotations and are seen as foundational to societal welfare.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">\"Socialization\" best captures the process the woman is undergoing as she adopts the practices of her new community.</span></p>",
      "correct_choice_id": 195689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59792,
      "choices": [
        {
          "id": 238469,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cohort study&nbsp;</span></span></span></p>"
        },
        {
          "id": 238470,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cross-sectional study&nbsp;</span></span></span></p>"
        },
        {
          "id": 238471,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Field trial</span></span></span></p>"
        },
        {
          "id": 238472,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Case-control study</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A study was carried out in three different states to analyze the average blood pressure within each community. Health workers were assigned to visit every household in these communities, and the mean blood pressure for each community was then calculated and compared. What study design best describes this research approach? (AIIMS NOV 2016)</span></span></p>",
      "unique_key": "Q3414218",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147515,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: B. Cross-sectional study</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cross-sectional study:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> A cross-sectional study examines a population at a single point in time. It captures a snapshot of the population&#39;s characteristics, including health outcomes like blood pressure, at that specific moment. The study described in the question aligns with this definition as health workers collected blood pressure data from individuals in different communities at one particular time.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Cohort study:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> A cohort study involves following a group of individuals over time to observe the development of outcomes. This study does not involve any follow-up period.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Field trial:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Field trials are interventional studies conducted on healthy individuals to assess the effectiveness of preventive measures.<br />\r\n\t&nbsp;This study doesn&#39;t involve any intervention.&nbsp;&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Case-control study:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> A case-control study starts with individuals who have a specific outcome (cases) and compares them to those without the outcome (controls) to identify potential risk factors. This study design is not applicable here.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A cross-sectional study is an observational study design that assesses a population at a specific point in time. It is often used to estimate the prevalence of a health condition or risk factor</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 238470,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11190,
      "choices": [
        {
          "id": 44726,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 44727,
          "text": "<p><span style=\"font-size:18px;\">2, 3</span></p>"
        },
        {
          "id": 44728,
          "text": "<p><span style=\"font-size:18px;\">1, 3</span></p>"
        },
        {
          "id": 44729,
          "text": "<p><span style=\"font-size:18px;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 45-year-old man has been diagnosed with tuberculosis. As part of his treatment plan, he is prescribed a combination of antitubercular drugs. While counseling him on the drug regimen, you explain the mechanisms of action of each drug. Which of the following combinations of statements accurately describe the mechanisms of some of the drugs used in treating tuberculosis? </strong><i><strong>[INICET NOV 2022]</strong></i></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Isoniazid inhibits mycolic acid synthesis</strong></span></li><li><span style=\"font-size:18px;\"><strong>Pyrazinamide is an enzyme inducer</strong></span></li><li><span style=\"font-size:18px;\"><strong>Rifampicin is used only in the treatment of tuberculosis</strong></span></li><li><span style=\"font-size:18px;\"><strong>Bedaquiline inhibits ATP synthase</strong></span></li></ol>",
      "unique_key": "Q6733346",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147576,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>1. lsoniazid -&nbsp;</strong>INH is activated by catalase peroxidase (formed by Kat G) enzyme of mycobacteria. It acts by inhibiting the formation of mycolic acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>4. Bedaquiline -</strong> Act by inhibiting ATP synthase enzyme, can result in QT prolongation</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>2. Pyrazinamide -&nbsp;</strong>Possess the best sterilizing activity (can kill slow growing bacteria) and makes the medium sterile. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. It is not an enzyme inducer.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>3. Rifampicin -&nbsp;</strong>Act by inhibiting RNA polymerase of mycobacteria by binding to its β-subunit. It thus inhibits transcription.<strong> </strong>Uses of Rifampicin are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Tuberculosis</span></li><li><span style=\"font-size:18px;\">Leprosy</span></li><li><span style=\"font-size:18px;\">DOC for Brucella (doxycycline + rifampicin)</span></li><li><span style=\"font-size:18px;\">Effective against Gram positive bacteria (including MRSA)</span></li><li><span style=\"font-size:18px;\">Effective against Gram negative bacteria (including Pseudomonas)</span></li><li><span style=\"font-size:18px;\">It was used for prophylaxis of meningococcus meningitis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Isoniazid inhibits mycolic acid synthesis.</span></li><li><span style=\"font-size:18px;\">Bedaquiline inhibits ATP synthase enzyme.</span></li><li><span style=\"font-size:18px;\">Pyrazinamide inhibits trans-translation</span></li><li><span style=\"font-size:18px;\">Rifampicin inhibit RNA polymerase</span></li></ul>",
      "correct_choice_id": 44729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20274,
      "choices": [
        {
          "id": 81057,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudogout</span></span></span></p>"
        },
        {
          "id": 81058,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute gout</span></span></span></p>"
        },
        {
          "id": 81059,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reactive arthritis</span></span></span></p>"
        },
        {
          "id": 81060,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Septic arthritis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A chronic alcoholic patient presents with acute pain and swelling of the left great toe. There is no history of trauma. Synovial fluid analysis shows raised leukocytes. Lab investigations show normal serum uric acid levels. What is the most likely diagnosis? (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q2994041",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147577,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Acute gout</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with acute pain and swelling in the left great toe, a common presentation of acute gout. Despite normal serum uric acid levels, the clinical presentation and the findings from the synovial fluid analysis point towards acute gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key Findings:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Pain and Swelling of the Left Great Toe:</span></strong><span style=\"font-size:12.0pt\"> This is characteristic of acute gout, especially involving the first metatarsophalangeal (MTP) joint.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">No History of Trauma:</span></strong><span style=\"font-size:12.0pt\"> This excludes traumatic causes of joint pain.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Synovial Fluid Analysis Shows Raised Leukocytes:</span></strong><span style=\"font-size:12.0pt\"> Indicates an inflammatory arthritis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Normal Serum Uric Acid Levels:</span></strong><span style=\"font-size:12.0pt\"> In 30-40% of acute gout cases, serum uric acid levels can be normal due to the uric acid being sequestered in the joint rather than in the bloodstream.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Gout&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints, leading to intense pain and swelling. The first MTP joint is the most commonly affected site. Acute gout can present with normal serum uric acid levels, particularly during an acute attack, due to the uric acid being sequestered in the joint.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis Confirmation:</span></strong><span style=\"font-size:12.0pt\"> The diagnosis of gout is confirmed by joint aspiration and identification of negatively birefringent needle-shaped crystals under polarized light microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pseudogout:</span></strong><span style=\"font-size:12.0pt\"> This condition usually presents in <strong>elderly individuals</strong> and often involves the knee or wrist joints. The presence of <strong>chondrocalcinosis on X-ray</strong> and the involvement of joints like knee (MC), wrist or MCP joint (NOT first MTP joint) makes pseudogout less likely in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Reactive Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically follows a gastrointestinal or genitourinary infection and involves multiple joints. There is no mention of such a history in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Septic Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition is usually associated with more severe systemic symptoms like fever and a more aggressive clinical course. The patient&#39;s presentation does not match the typical features of septic arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educaitonal Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute gout can present with normal serum uric acid levels, especially during an acute attack, and the involvement of the first metatarsophalangeal (MTP) joint is highly characteristic of this condition.</span></span></p>",
      "correct_choice_id": 81058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44868,
      "choices": [
        {
          "id": 179119,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 179120,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 2 and 4</span></p>"
        },
        {
          "id": 179121,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4 and 2</span></p>"
        },
        {
          "id": 179122,
          "text": "<p><span style=\"font-size:12pt;\">4, 2, 1 and 3</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Many GPCR receptors act via increase in cAMP. There are several steps involved in this mechanism as given below. Which of the following is correct sequence of events in cAMP signal transduction pathway? (</span>INICET May 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Steps involved</span></p><p><br><span style=\"font-size:12.0pt;\">1. Activation of adenylate cyclase</span><br><span style=\"font-size:12.0pt;\">2. Activation of PKA</span><br><span style=\"font-size:12.0pt;\">3. Conversion of ATP to cAMP</span><br><span style=\"font-size:12.0pt;\">4. Phosphorylation of target proteins</span></p>",
      "unique_key": "Q2011234",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147578,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 1, 3, 2 and 4</strong></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence of events in the cAMP signal transduction pathway is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Activation of adenylate cyclase</span></li><li><span style=\"font-size:12pt;\">Conversion of ATP to cAMP</span></li><li><span style=\"font-size:12pt;\">Activation of PKA</span></li><li><span style=\"font-size:12pt;\">Phosphorylation of target proteins</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. 1, 3, 2 and 4</strong></span></p>",
      "correct_choice_id": 179120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13762,
      "choices": [
        {
          "id": 55009,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-3, C-2, D-4</span></span></p>"
        },
        {
          "id": 55010,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-4, C-1, D-2</span></span></p>"
        },
        {
          "id": 55011,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-2, C-1, D-4</span></span></p>"
        },
        {
          "id": 55012,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-4, D-1</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following:</span></span>(INICET MAY 2022)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/screenshot-2023-10-28-190216.jpg\" style=\"height:319px; width:700px\" /></span></span></p>",
      "unique_key": "Q6956126",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147579,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) A-3, B-2, C-1, D-4</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The chronology of eruption of secondary dentition or permanent teeth is as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Canine:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 11-12 years (A-3)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lateral incisor:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 8-9 years (B-2)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">First molar:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 6-7 years (C-1)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Third molar:</span></strong><span style=\"font-size:12.0pt\"> Erupts at 17-25 years (D-4)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronology of eruption of secondary dentition or permanent teeth:</span></span></strong><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/screenshot-2023-10-28-190347.jpg\" style=\"height:861px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mnemonic: <strong>M</strong>other <strong>I</strong>s <strong>I</strong>n <strong>P</strong>ain <strong>P</strong>apa <strong>C</strong>an <strong>M</strong>ake <strong>M</strong>edicine</span></span></span></p>",
      "correct_choice_id": 55011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13789,
      "choices": [
        {
          "id": 55117,
          "text": "<p><span style=\"font-size:12.0pt;\">Syndesmosis</span></p>"
        },
        {
          "id": 55118,
          "text": "<p><span style=\"font-size:12.0pt;\">Synarthrosis</span></p>"
        },
        {
          "id": 55119,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchondrosis</span></p>"
        },
        {
          "id": 55120,
          "text": "<p><span style=\"font-size:12.0pt;\">Synovial</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What type of joint is demonstrated in the highlighted region of the vertebral articulation shown?&nbsp;</span>(NEET PG 2020)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-889.jpg\" alt=\"\" width=\"300\" height=\"141\"></p>",
      "unique_key": "Q2983683",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147580,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Synovial</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The joint marked in the above image is a synovial joint called the costotransverse and costovertebral joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These are the most common type of joints in the body. The articulating ends of the bones in these joints are covered with articular cartilage. These bones are enclosed within an articular capsule which has an outer fibrous layer (giving it strength) and an inner synovial membrane which secretes synovial fluid (providing lubrication and nutrients to the joint). Examples include the knee joint, elbow joint, and many others.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They are diarthrotic, meaning they are freely movable. The exact range of movement and type of movement (e.g., hinge, pivot, ball-and-socket) varies depending on the specific joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Syndesmosis</strong>: This is a type of fibrous joint where the bones are joined by a ligament or a membrane. The most commonly referred syndesmosis is the one between the tibia and fibula in the leg, held together by the interosseous membrane and the anterior and posterior tibiofibular ligaments.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It allows for a slight movement (making it amphiarthrotic), particularly when the foot is dorsiflexed or plantarflexed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Synarthrosis</strong>: This term describes a joint that allows very minimal or no movement. It encompasses several types of joints including sutures (between skull bones), gomphoses (between a tooth and its socket), and synchondroses (which we'll discuss next).</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">These are largely immovable joints. They serve to provide stability in certain areas of the body, like the skull, where movement is not desired.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Synchondrosis</strong>: This is a subtype of synarthrosis, and it's a type of cartilaginous joint where bones are joined together by hyaline cartilage. A classic example is the joint between the first rib and the sternum, or the epiphyseal plates in growing bones.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">They are immovable (synarthrotic). The primary purpose of these joints is to allow growth of the bone while providing stability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Description of the joint present in the thoracic region are as follows:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/07/screenshot-2023-11-07-181747.jpg\" alt=\"\" width=\"1000\" height=\"742\"></p>",
      "correct_choice_id": 55120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9992,
      "choices": [
        {
          "id": 39934,
          "text": "<p><span style=\"font-size:12.0pt;\">SOX11</span></p>"
        },
        {
          "id": 39935,
          "text": "<p><span style=\"font-size:12.0pt;\">ITRA 1</span></p>"
        },
        {
          "id": 39936,
          "text": "<p><span style=\"font-size:12.0pt;\">MYD88</span></p>"
        },
        {
          "id": 39937,
          "text": "<p><span style=\"font-size:12.0pt;\">Annexin V</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following Immunohistochemistry marker is used in Cyclin D1 negative Mantle cell lymphoma?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p>",
      "unique_key": "Q7403156",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147581,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) SOX11</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mantle cell lymphoma is an uncommon lymphoid neoplasm that makes up about 2.5% of NHL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The tumor cells closely resemble the normal mantle zone B cells that surround germinal centers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Typically, the proliferation consists of a homogeneous population of small lymphocytes with irregular to occasionally deeply clefted (cleaved) nuclear contours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immunohistochemistry - Mantle cell lymphomas express high levels of <strong>cyclin D1</strong>. Most tumors are <strong>also express CD19, CD20,</strong> and moderately high levels of surface Ig (usually IgM and IgD with κ or γ light chain). It is <strong>usually CD5+ and CD23-,</strong> <u>which helps to distinguish it from CLL/SLL</u>. The IgH genes lack somatic hypermutation, supporting an origin from a naive B cell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cyclin D1 (CCND1) protein overexpression and/or the t(11;14) </strong>(q13;q32) translocation are the pathognomonic hallmarks of mantle cell lymphoma (MCL). <strong>SOX11 expression serves as a specific biomarker in cases lacking both t (11;14) and cyclin D1 protein </strong>but having a gene expression profile suggestive of MCL. SOX11 expression is <strong>associated with bad prognosis in mantle cell lymphoma.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>MYD88</strong>: Associated with Waldenström macroglobulinemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Annexin V</strong>: Generally used in apoptosis studies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>DDs of NHL: -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-173853.png\" alt=\"\" width=\"1000\" height=\"279\"></strong></span></p>",
      "correct_choice_id": 39934,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55886,
      "choices": [
        {
          "id": 222977,
          "text": "<p><span style=\"font-size:12.0pt;\">Midbrain</span></p>"
        },
        {
          "id": 222978,
          "text": "<p><span style=\"font-size:12.0pt;\">Pons</span></p>"
        },
        {
          "id": 222979,
          "text": "<p><span style=\"font-size:12.0pt;\">Medulla</span></p>"
        },
        {
          "id": 222980,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical spinal segment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In given image, nucleus of marked nerve is related to (INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-162807.jpeg\" alt=\"\" width=\"400\" height=\"333\"></span></p>",
      "unique_key": "Q4045913",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147582,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Cervical spinal segment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nerve marked in the image is the phrenic nerve. The phrenic nerve is primarily responsible for innervating the diaphragm, which is crucial for breathing. The mnemonic \"3, 4, 5 keeps the diaphragm alive\" helps to remember that the phrenic nerve arises from the cervical spinal segments C3, C4, and C5. This nerve travels downward, passing in front of the lung root, to reach the diaphragm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-200439.jpeg\" alt=\"\" width=\"741\" height=\"779\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Midbrain:</strong> The midbrain is not involved in the origin of the phrenic nerve. The midbrain primarily deals with functions such as vision, hearing, motor control, sleep/wake, arousal, and temperature regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pons:</strong> The pons is involved in various functions including breathing, communication between different parts of the brain, and sensations such as hearing, taste, and balance. However, it does not give rise to the phrenic nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Medulla: </strong>The medulla oblongata regulates vital functions such as heart rate, breathing, and blood pressure. While it contains nuclei for several cranial nerves, it is not the origin of the phrenic nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The phrenic nerve originates from the cervical spinal segments C3, C4, and C5, and is essential for diaphragm movement and breathing.</span></p>",
      "correct_choice_id": 222980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10111,
      "choices": [
        {
          "id": 40410,
          "text": "<p><span style=\"font-size:12.0pt;\">1+</span></p>"
        },
        {
          "id": 40411,
          "text": "<p><span style=\"font-size:12.0pt;\">2+</span></p>"
        },
        {
          "id": 40412,
          "text": "<p><span style=\"font-size:12.0pt;\">3+</span></p>"
        },
        {
          "id": 40413,
          "text": "<p><span style=\"font-size:12.0pt;\">Gene Amplification is done irrespective of Her 2 Neu status</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In breast cancer, FISH for gene amplification will be done based on which of the following IHC staining for Her-2/neu?&nbsp;</span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q2405330",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147583,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2+</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of breast cancer, the <strong>Her-2/neu</strong> status is typically assessed by <strong>Immunohistochemistry (IHC)</strong>. The Her-2/neu protein overexpression is graded on a scale of 0 to 3+ based on the intensity and completeness of membrane staining. This grading is crucial in guiding further testing and treatment decisions.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>IHC 0 or 1+</strong>: These scores indicate no or low levels of Her-2/neu expression, respectively. Tumors with these scores are considered Her-2 negative, and no further testing for gene amplification is typically needed.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 2+</strong>: This score is considered <strong>equivocal</strong>. When a tumor shows a 2+ result on IHC, it suggests an intermediate level of Her-2/neu expression. Because this result is not definitively positive or negative, <strong>Fluorescence in Situ Hybridization (FISH)</strong> testing is recommended to assess for <strong>gene amplification</strong> of Her-2/neu. FISH is a more sensitive and specific test that directly detects the amplification of the Her-2/neu gene, providing definitive information about the tumor's status.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 3+</strong>: A score of 3+ indicates a high level of Her-2/neu protein overexpression. Tumors with this score are considered <strong>Her-2 positive</strong> and typically do not require further FISH testing, as the overexpression is sufficient to warrant Herceptin (trastuzumab) therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Herceptin</strong> is a targeted therapy that specifically inhibits the Her-2/neu receptor, which is overexpressed in some breast cancers, leading to more aggressive tumor behavior. Therefore, determining the correct Her-2/neu status through IHC and, if necessary, confirming with FISH is crucial in selecting the appropriate treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1+:</strong> IHC 1+ is considered Her-2/neu negative, and FISH testing is generally not indicated in these cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 3+:</strong> IHC 3+ is strongly positive for Her-2/neu, making FISH testing unnecessary since the high expression level is sufficient to guide treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gene Amplification is done irrespective of Her 2 Neu status:</strong> This option is incorrect because FISH testing for gene amplification is specifically indicated in cases with an equivocal IHC result (2+), not irrespective of Her-2/neu status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FISH for Her-2/neu gene amplification is performed when the IHC result is 2+, as this score is considered equivocal, requiring further testing to determine the appropriate therapeutic approach.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-367.jpg\" alt=\"\" width=\"500\" height=\"791\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/42.jpg\" alt=\"\" width=\"406\" height=\"445\"></span></p>",
      "correct_choice_id": 40411,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6532,
      "choices": [
        {
          "id": 26097,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits the release of acetylcholine</span></p>"
        },
        {
          "id": 26098,
          "text": "<p><span style=\"font-size:12.0pt;\">Release of noradrenaline at synaptic cleft</span></p>"
        },
        {
          "id": 26099,
          "text": "<p><span style=\"font-size:12.0pt;\">Selectively and irreversibly inhibits nicotinic receptors</span></p>"
        },
        {
          "id": 26100,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates muscarinic and nicotinic receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman received a Botox injection for the treatment of wrinkles.&nbsp; Which of the following is the mechanism of action of botulinum toxin?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q6232382",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147584,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Inhibits the release of acetylcholine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The botulinum toxin works by preventing acetylcholine from entering the synaptic cleft. Acetylcholine is exocytosed by SNARE protein, which is broken down by botulinum toxin. Consequently, it prevents acetylcholine from being released.</span></li><li><span style=\"font-size:12.0pt;\">Other agents that regulate the level of Ach in the synapse are:</span><ul><li><span style=\"font-size:12.0pt;\">Hemicholinium acts by inhibiting choline uptake (the rate limiting step in the synthesis of acetylcholine)</span></li><li><span style=\"font-size:12.0pt;\">Vesamicol inhibits the uptake of Acetylcholine into the vesicles.</span></li><li><span style=\"font-size:12.0pt;\">Physostigmine inhibits the breakdown of Ach at the synaptic cleft by the action of Acetylcholine esterase.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Release of noradrenaline at synaptic cleft:&nbsp;</strong>Botulinum toxin does not facilitate the release of noradrenaline. Its primary action is on the cholinergic neurons where it inhibits the release of acetylcholine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Selectively and irreversibly inhibits nicotinic receptors:&nbsp;</strong>Botulinum toxin does not directly inhibit nicotinic receptors. Instead, it prevents the release of acetylcholine, which means there is no neurotransmitter available to bind to and activate the nicotinic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Stimulates muscarinic and nicotinic receptors:&nbsp;</strong>Botulinum toxin does not stimulate muscarinic or nicotinic receptors. In fact, it decreases neurotransmission by preventing the release of acetylcholine, which would otherwise stimulate these receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Botulinum toxin inhibits the release of acetylcholine by cleaving SNARE proteins, thereby preventing neurotransmission at the neuromuscular junction and leading to muscle relaxation.</span></p>",
      "correct_choice_id": 26097,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24732,
      "choices": [
        {
          "id": 98889,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Light blue &rarr; Red &rarr; Lavender &rarr; Grey</span></span></span></p>"
        },
        {
          "id": 98890,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Light blue &rarr; Lavender &rarr; Red &rarr; Grey</span></span></span></p>"
        },
        {
          "id": 98891,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Grey &rarr; Red &rarr; Light blue &rarr; Lavender</span></span></span></p>"
        },
        {
          "id": 98892,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Red &rarr; Lavender &rarr; Grey &rarr; Light blue</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The phlebotomist needs to collect samples from a patient for various tests. Among the options provided, which sequence of blood collection for testing ensures that the sample remains uncontaminated, considering the additives present in the collection tubes?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
      "unique_key": "Q6861202",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Light blue &rarr; Red &rarr; Lavender &rarr; Grey</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Clinical &amp; Laboratory Standards Institute (CLSI) has provided a recommended color sequence for collecting multiple venous and/or arterial blood samples from a single patient: Yellow, Pink, Light Blue, Red, Green, Lavender, And Grey.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The accurate color sequence for the blood collection tubes is as follows: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Light blue <strong>&rarr;</strong> Red <strong>&rarr;</strong> Lavender <strong>&rarr;</strong> Grey</span></span></span></p>",
      "correct_choice_id": 98889,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59793,
      "choices": [
        {
          "id": 238473,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Nominal Scale</span></span></span></p>"
        },
        {
          "id": 238474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Ordinal Scale</span></span></span></p>"
        },
        {
          "id": 238475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Metric Scale</span></span></span></p>"
        },
        {
          "id": 238476,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nominal Categorical Scale</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A neurology resident is assessing a patient with a recent traumatic brain injury and uses the Glasgow Coma Scale (GCS) to evaluate the patient&rsquo;s level of consciousness and neurological responses. During a teaching session, the resident asks a medical student about the nature of the data generated by the GCS and how it should be interpreted in terms of data classification. What type of data does the GCS score represent?</span></span></span></p>",
      "unique_key": "Q6365514",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147586,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Ordinal Scale</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The Glasgow Coma Scale (GCS) is used to assess the level of consciousness in patients with brain injury by assigning scores to eye, verbal, and motor responses. These scores are then summed to classify the severity of the injury into mild, moderate, or severe categories. The GCS score is an example of ordinal data because the categories follow a specific order or rank (i.e., increasing severity), but the differences between scores are not necessarily equal or measurable in precise terms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong> </strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Nominal Scale:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Nominal scales classify data into distinct categories without any order or ranking. Examples include variables like gender, blood type, or race, which do not have a specific sequence or hierarchy. The GCS does not fall under this category because it involves a ranked classification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong> </strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Metric Scale:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Metric scales involve quantitative measurements that have equal intervals between values, such as weight, height, or temperature. This scale is used for continuous data where precise measurements can be made. The GCS is not metric because its scores are ranked but not measured with equal intervals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><strong> </strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Nominal Categorical Scale:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Nominal categorical scales involve qualitative data classified into groups without any inherent order, similar to the nominal scale. The GCS score, however, involves a ranking order, making this an incorrect classification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The Glasgow Coma Scale (GCS) produces ordinal data as it classifies the severity of brain injury in a ranked order, such as mild, moderate, or severe. Understanding the nature of the data type generated by clinical assessment tools like the GCS helps in appropriate data analysis and interpretation in clinical practice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture3_hZpNnkM.jpg\" style=\"height:629px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 238474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11459,
      "choices": [
        {
          "id": 45802,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid Arthritis</span></span></span></span></p>"
        },
        {
          "id": 45803,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osteoarthritis</span></span></span></span></p>"
        },
        {
          "id": 45804,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex Regional Pain Syndrome</span></span></span></span></p>"
        },
        {
          "id": 45805,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Villonodular synovitis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly woman presents with a chronic history of pain in the small joints of hands with stiffness of joints in the early hours of the day. The image of the patient&#39;s hands is given below. What is the most likely diagnosis? (AIIMS MAY 2018)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm64.jpg\" style=\"height:314px; width:300px\" /></span></span></p>",
      "unique_key": "Q9502587",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147587,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Rheumatoid Arthritis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early diagnosis of RA is crucial. May present with mono/oligoarthritis. Inflammation (stiffness &gt; 30 mins) is significant.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RA +ve: 70%, anti-CCP+ve:75%. <em>Hence 1/5th SERONEGATIVE</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rule out Psoriatic arthritis, Crystal arthropathies, CTD, Hansens, Polymyalgia rheumatica before labeling seronegative RA</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Get baseline CBC, LFT, RFT, HbsAg, Anti-HCV</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start DMARD - Mtx 7.5-10 mg/week, gradually </span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&uarr; to</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 25 mg/wk. Avoid DMARDs cocktail.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OA usually morning stiffness &lt;15-30 mins. Bouchard, Heberden nodes in late stages.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex regional pain syndrome (CRPS) is a condition that can develop after <strong>peripheral nerve injury</strong>, wherein patients experience unprovoked pain in the area supplied by the affected nerve. Sympathetic innervation to the affected area can be disrupted, and blocking this sympathetic activity with a local anesthetic can sometimes alleviate the pain. Notably, damaged nerve fibers become sensitive to adrenergic signals, allowing them to be activated by the sympathetic nervous system. This constellation of symptoms, including <strong>spontaneous pain and signs of disrupted sympathetic function</strong>, characterizes CRPS.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Villonodular Synovitis is&nbsp;</span></strong></span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">c</span>haracterized by joint swelling due to excess synovial growth and potential bleeding into the joint, leading to pain and restricted movement, which is less likely given the chronic symmetrical joint involvement typical of RA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid Arthritis is suggested by the presence of symmetrical small joint pain and stiffness, particularly in the morning, with potential visible joint deformities. Early and aggressive treatment is vital to manage symptoms and prevent progressive joint damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatology/RA/Chap&nbsp; </span></span></strong></span></span></p>",
      "correct_choice_id": 45802,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43278,
      "choices": [
        {
          "id": 172779,
          "text": "<p><span style=\"font-size:12.0pt;\">CT</span></p>"
        },
        {
          "id": 172780,
          "text": "<p><span style=\"font-size:12.0pt;\">Sestamibi SPECT</span></p>"
        },
        {
          "id": 172781,
          "text": "<p><span style=\"font-size:12.0pt;\">Tc99-Sestamibi scan</span></p>"
        },
        {
          "id": 172782,
          "text": "<p><span style=\"font-size:12.0pt;\">USG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the below is the most preferred investigation for parathyroid adenoma localisation? (INICET Nov 2023)</span></p>",
      "unique_key": "Q2350668",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147588,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Sestamibi SPECT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the preferred diagnostic tool for identifying parathyroid adenomas. The technique involves the use of a radioactive tracer, typically Technetium-99m sestamibi, which is absorbed by hyperactive parathyroid tissue more than normal tissue. SPECT provides three-dimensional imaging, improving the localization of hyperactive parathyroid glands.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CT (Computed Tomography):</strong> CT scans are not typically the first line of imaging due to the high levels of radiation exposure and the potential need for contrast agents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Technetium-99m Sestamibi (tech99-Sestamibi) scan:</strong> This is a nuclear imaging which uses a gamma camera for imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. USG (Ultrasound):</strong> Ultrasound is a non-invasive, widely available, and less expensive method to examine the neck for parathyroid adenomas. It is particularly useful in conjunction with Sestamibi scans, as it helps to evaluate the structure of the neck and localize adenomas. However, its effectiveness can be limited by the operator's experience and the patient's anatomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While all these methods can assist in the diagnosis and localization of parathyroid adenomas, Sestamibi SPECT is generally considered the most effective standalone imaging modality due to its high specificity for active parathyroid tissue and its ability to provide detailed spatial resolution. It is particularly valuable in surgical planning to ensure precise removal of the adenoma.</span></p>",
      "correct_choice_id": 172780,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14011,
      "choices": [
        {
          "id": 56005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APC, BRCA, K-RAS</span></span></span></p>"
        },
        {
          "id": 56006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APC, K-RAS, p53</span></span></span></p>"
        },
        {
          "id": 56007,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MYH, K-RAS, APC</span></span></span></p>"
        },
        {
          "id": 56008,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MYH, p53, DCC</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male patient presented with complaints of persistent abdominal pain and altered bowel movements. On performing a colonoscopy, a carcinoma of the colon was detected. The biopsy report showed the presence of gene mutations in the tumor tissue. What are the common gene mutations seen in carcinoma of the colon? (</span></span></span>INICET May 2020)</p>",
      "unique_key": "Q3977096",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147589,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) APC, K-RAS, p53</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma of the colon is frequently associated with mutations in three key genes: APC, K-RAS, and p53. The sequence of genetic events typically begins with the loss of function mutations in the APC gene, leading to early adenomatous changes. Subsequent mutations in K-RAS drive the progression towards a more aggressive adenomatous stage, and alterations in p53 typically occur later, contributing to the transition from adenoma to carcinoma. The combined effects of these mutations disrupt normal cell growth controls and apoptosis, leading to unchecked cell proliferation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A. APC, BRCA, K-RAS </strong>is primarily associated with breast and ovarian cancers, not typically with colon cancer. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span>MYH, K-RAS, APC&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is involved in a polyposis condition which can lead to colon cancer but is not as commonly mutated in sporadic cases as APC, K-RAS, or p53.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp;</span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\">Option D.&nbsp;</span></span></span>MYH, p53, DCC</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;gene does play a role in colon cancer, but it&#39;s not as commonly mutated as APC, K-RAS, or p53. MYH, along with p53, isn&#39;t a primary mutation for sporadic colon cancers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize APC, K-RAS, and p53 as the most common mutations in carcinoma of the colon, emphasizing the molecular pathogenesis of colorectal cancer.</span></span></span></p>",
      "correct_choice_id": 56006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6469,
      "choices": [
        {
          "id": 25845,
          "text": "<p><span style=\"font-size:12.0pt;\">Domperidone</span></p>"
        },
        {
          "id": 25846,
          "text": "<p><span style=\"font-size:12.0pt;\">Tegaserod</span></p>"
        },
        {
          "id": 25847,
          "text": "<p><span style=\"font-size:12.0pt;\">Granisetron</span></p>"
        },
        {
          "id": 25848,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxylamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most effective antiemetic for chemotherapy-induced vomiting is: (NEET PG 2019)</span></p>",
      "unique_key": "Q6711544",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147590,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Granisetron</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Granisetron is a 5-HT3 receptor antagonist that is highly effective for preventing chemotherapy-induced nausea and vomiting (CINV). These drugs have become the standard of care for managing moderate to highly emetogenic chemotherapy agents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Domperidone</strong>: Domperidone is a dopamine receptor antagonist used for the treatment of nausea and vomiting, but it is generally not as effective as 5-HT3 receptor antagonists like Granisetron for managing chemotherapy-induced vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Tegaserod</strong>: Tegaserod is primarily used for treating irritable bowel syndrome (IBS) with constipation and is not an antiemetic. It acts as a 5-HT4 receptor agonist to promote gastrointestinal motility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Doxylamine:</strong> Doxylamine is an antihistamine that can be used for nausea and vomiting during pregnancy, often in combination with pyridoxine (vitamin B6). It is not the most effective option for chemotherapy-induced vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the most effective antiemetic for chemotherapy-induced vomiting is Granisetron, making option C the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Granisetron, a 5-HT3 receptor antagonist, is the most effective antiemetic for preventing chemotherapy-induced nausea and vomiting (CINV). It is the standard of care for managing nausea and vomiting associated with moderate to highly emetogenic chemotherapy agents.</span></p>",
      "correct_choice_id": 25847,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10079,
      "choices": [
        {
          "id": 40282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Is both intra and extra cellular</span></span></span></p>"
        },
        {
          "id": 40283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Can fuse with other organelles directly</span></span></span></p>"
        },
        {
          "id": 40284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fuses with lysosome to form autophagolysosome</span></span></span></p>"
        },
        {
          "id": 40285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Is a single membrane structure</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What can be the mechanism by which phagolysosome cause cell death in autophagy?</span> <span style=\"font-size:12.0pt\">(INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q8822625",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147728,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Fuses with lysosome to form autophagolysosome</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phagolysosome cause cell death by fusing with lysosome to form autophagolysosome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autophagy refers to lysosomal digestion of the cell&rsquo;s own components. It is a survival mechanism in times of nutrient deprivation, so a cell can thrive by recycling its own contents.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture10_IsDgi6X.jpg\" style=\"height:150px; width:600px\" /></span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Is both intra and extracellular</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Autophagy is an intracellular process, not extracellular. It involves the internal digestion of cellular components and does not occur outside the cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Can fuse with other organelles directly</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While autophagic vacuoles can engulf other organelles, the crucial step in autophagy involves the fusion with a lysosome to form the autophagolysosome, where degradation occurs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Is a single membrane structure</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The autophagic vacuole is initially a double-membrane structure that eventually fuses with a lysosome. The formation of the autophagolysosome is key to the degradation process in autophagy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The fusion of an autophagic vacuole with a lysosome to form an autophagolysosome is a central step in the autophagy process, enabling the degradation and recycling of cellular components.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 72</span></strong></span></span></p>",
      "correct_choice_id": 40284,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11710,
      "choices": [
        {
          "id": 46806,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid sinus massage</span></p>"
        },
        {
          "id": 46807,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 46808,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blocker</span></p>"
        },
        {
          "id": 46809,
          "text": "<p><span style=\"font-size:12.0pt;\">Defibrillator</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A Patient came with sudden onset palpitations. ECG showed narrow complex, regular tachycardia without P waves, and a rate of 160bpm. His BP is 96/68mmHg. What is the next step in management? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q4419626",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147729,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Carotid sinus massage.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Above ECG findings – narrow complex tachycardia without P waves with clinical finding of sudden onset palpitations suggest AV node reentrant tachycardia (AVNRT).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Next best step in management will be carotid sinus massage (or any other vagal maneuver).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vagal maneuvers can terminate an approximate 10-20% of AVNRT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adenosine:&nbsp;</strong>Used if vagal maneuver fail, adenosine is the drug of choice because it can temporarily block AV node conduction and terminate reentrant tachycardias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Beta blocker:&nbsp;</strong>Beta blockers are another pharmacological option if adenosine fails, used to slow the heart rate and control the symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Defibrillator:&nbsp;</strong>Not appropriate in this scenario as the patient is hemodynamically stable (SBP &gt;90 mmHg) and the tachycardia does not pose an immediate threat to life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carotid sinus massage is the first-line intervention for clinically stable patients presenting with AVNRT, potentially stopping the arrhythmia without the need for drug intervention.</span></p>",
      "correct_choice_id": 46806,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7169,
      "choices": [
        {
          "id": 28644,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topically applied sulfonamide antibacterial</span></span></span></p>"
        },
        {
          "id": 28645,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical ocular carbonic anhydrase inhibitor</span></span></span></p>"
        },
        {
          "id": 28646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Second-generation sulfonylurea</span></span></span></p>"
        },
        {
          "id": 28647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid receptor agonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide is a:&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q5439806",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147730,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B. Topical ocular carbonic anhydrase inhibitor</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide is a topical ocular carbonic anhydrase inhibitor. It helps in decreasing the rate of formation of aqueous humor in the eye, therefore useful in the management of glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A. Topically applied sulfonamide antibacterial</strong> agents include silver sulfadiazine, Mafenide acetate, sulfacetamide etc.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C. Second-Generation Sulfonylureas</strong> are oral antidiabetic agents which act via increasing sensitivity of the insulin receptors and stimulate the release of insulin from the pancreas. It is used to manage type-2 diabetes mellitus. It includes Glipizide, Glyburide etc.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D. Opioid receptor agonist</strong> is the class of drugs which bind to the opioid receptors in the body. It includes Morphine, Pethidine, Fentanyl etc.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide is a topical ocular carbonic anhydrase inhibitor used to reduce intraocular pressure by decreasing the production of aqueous humor, making it effective in the treatment of glaucoma. This distinguishes it from sulfonamide antibacterials, second-generation sulfonylureas, and opioid receptor agonists, which are used for different medical conditions.</span></span></span></p>",
      "correct_choice_id": 28645,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11337,
      "choices": [
        {
          "id": 45314,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lambert Eaton Myasthenic Syndrome</span></span></p>"
        },
        {
          "id": 45315,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia Gravis</span></span></p>"
        },
        {
          "id": 45316,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral Neuropathy</span></span></p>"
        },
        {
          "id": 45317,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duchenne Muscular Dystrophy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 76-year-old man presented with generalized weakness, which increased towards the evening and improved with 5-10 minutes of rest in between. On examination, he also had ptosis and some difficulty in swallowing. What is the likely diagnosis?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q2938413",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147731,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Myasthenia Gravis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia Gravis (MG) is characterized by fluctuating muscle weakness and fatigability, which typically worsens with activity and improves with rest. The hallmark of MG is weakness that is more pronounced towards the end of the day or after prolonged activity, and this weakness improves after a period of rest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Key features in this patient&rsquo;s presentation include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Generalized weakness that increases in the evening.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Improvement in weakness with short rest periods.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of ptosis (drooping eyelids) and difficulty in swallowing, which are common manifestations of MG.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In MG, autoantibodies attack the acetylcholine receptors at the neuromuscular junction, impairing neuromuscular transmission. This leads to the characteristic symptoms of fluctuating weakness and fatigability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Lambert Eaton Myasthenic Syndrome:</span></strong><span style=\"font-size:12.0pt\"> Lambert Eaton Myasthenic Syndrome (LEMS) is a paraneoplastic syndrome often associated with small cell lung cancer. It also involves muscle weakness but typically improves with exercise rather than worsening, which is opposite to the pattern seen in MG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Peripheral Neuropathy:</span></strong><span style=\"font-size:12.0pt\"> Peripheral neuropathy generally presents with sensory disturbances, weakness, and diminished reflexes in a stocking-glove distribution. It does not typically cause fluctuating weakness or specific muscle group involvement such as ptosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Duchenne Muscular Dystrophy:</span></strong><span style=\"font-size:12.0pt\"> Duchenne Muscular Dystrophy (DMD) is a genetic disorder that presents in early childhood with progressive muscle weakness, particularly in the proximal muscles. It is highly unlikely to present in a 76-year-old man as it typically leads to severe disability or death by early adulthood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia Gravis is characterized by fluctuating muscle weakness that worsens with activity and improves with rest. Key clinical features include ptosis, difficulty swallowing, and generalized weakness with a diurnal variation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most sensitive diagnosis is supported by single fiber EMG and most specific investigation is antibody tests, such as acetylcholine receptor antibodies and </span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">anti-muscle specific kinase antibodies.</span></span></p>",
      "correct_choice_id": 45315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9949,
      "choices": [
        {
          "id": 39762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Graft versus host disease</span></span></span></p>"
        },
        {
          "id": 39763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HLA Alloimmunization</span></span></span></p>"
        },
        {
          "id": 39764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immunomodulation</span></span></span></p>"
        },
        {
          "id": 39765,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion Related Acute Lung Injury (TRALI)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transfusing irradiated red blood cells (RBCs) can effectively prevent which of the following conditions? (AIIMS MAY 2021) </span></span></p>",
      "unique_key": "Q9395616",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;A) Graft versus host disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transfusing irradiated red blood cells (RBCs) can effectively prevent <strong>transfusion-associated Graft-Versus-Host Disease (TA-GVHD)</strong>. TA-GVHD is a rare but serious complication that can occur when viable T lymphocytes present in the transfused blood product proliferate and attack the recipient&#39;s tissues. This is particularly dangerous in immunocompromised individuals or those receiving blood from close relatives where the donor lymphocytes are not recognized as foreign by the recipient&#39;s immune system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Irradiation of blood products helps to inactivate T lymphocytes, thereby preventing their proliferation and reducing the risk of TA-GVHD. This is crucial in certain patient populations, such as those undergoing bone marrow transplantation, those with congenital immunodeficiency disorders, and patients receiving blood from relatives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. HLA alloimmunization</span></strong><span style=\"font-size:12.0pt\">: HLA alloimmunization refers to the development of antibodies against human leukocyte antigens (HLA) due to exposure to foreign antigens through transfusions or pregnancy. It is not specifically prevented by irradiating blood products.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Immunomodulation</span></strong><span style=\"font-size:12.0pt\">: Immunomodulation refers to the modulation of the immune response by transfused blood products, which is not specifically targeted by irradiation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transfusion-related acute lung injury (TRALI)</span></strong><span style=\"font-size:12.0pt\">: Transfusion-related acute lung injury (TRALI) is a rare but severe reaction that causes acute respiratory distress following transfusion. It is primarily caused by antibodies in the transfused blood reacting with the recipient&#39;s leukocytes, not by the presence of viable T lymphocytes, so irradiation does not prevent TRALI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The use of <strong>irradiated RBCs</strong> is specifically recommended to prevent <strong>Graft-Versus-Host Disease (GVHD)</strong>, making it the correct answer for this scenario.</span></span></span></p>",
      "correct_choice_id": 39762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1937,
      "choices": [
        {
          "id": 7741,
          "text": "<p><span style=\"font-size:12.0pt;\">Kcat/Km</span></p>"
        },
        {
          "id": 7742,
          "text": "<p><span style=\"font-size:12.0pt;\">Km/Kcat</span></p>"
        },
        {
          "id": 7743,
          "text": "<p><span style=\"font-size:12.0pt;\">Km/Ka</span></p>"
        },
        {
          "id": 7744,
          "text": "<p><span style=\"font-size:12.0pt;\">Ka/Km</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The catalytic efficiency of enzyme is best expressed by which of the following kinetic constants? (</span>AIIMS May 2019)</p>",
      "unique_key": "Q3210389",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147733,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Kcat/Km</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>catalytic efficiency is the ratio of Kcat/Km.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kcat is the first-order rate constant that <strong>determines the reaction rate</strong> when the enzyme is fully occupied at a saturating concentration of the substrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Michaelis constant (Km), defined as the concentration of substrate that is transported at half the maximal velocity (Vmax) of transport, is a <strong>measure of the affinity of the transporter for its substrate.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Decreasing the catalytic efficiency or the quantity of the catalyst for the <strong>\"bottleneck\" or rate-limiting reaction</strong> therefore reduces metabolite flux through the entire pathway. Conversely, an increase in either its quantity or catalytic efficiency enhances flux through the pathway as a whole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The catalytic efficiency of an enzyme is best expressed by the ratio Kcat/Km, as it provides a measure of how effectively the enzyme converts substrate into product, considering both the enzyme's turnover rate and its substrate affinity.</span></p>",
      "correct_choice_id": 7741,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59794,
      "choices": [
        {
          "id": 238477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Azithromycin and Doxycycline</span></span></span></p>"
        },
        {
          "id": 238478,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cefixime and Metronidazole</span></span></span></p>"
        },
        {
          "id": 238479,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Azithromycin and Cefixime</span></span></span></p>"
        },
        {
          "id": 238480,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penicillin and Fluconazole</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Dr. Rajan, a consultant at a primary health center, often manages sexually transmitted infections (STIs) using a syndromic approach due to limited diagnostic facilities. A 28-year-old male patient presents with urethral discharge, painful urination, and mild scrotal swelling but denies any history of systemic symptoms such as fever. On examination, there is no significant inguinal lymphadenopathy. Given the patient&#39;s symptoms and the need to address both gonococcal and non-gonococcal causes of urethritis without specific laboratory tests, which of the following medication combinations would be the most appropriate for syndromic management?</span></span></span></p>",
      "unique_key": "Q7339370",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147734,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Azithromycin and Cefixime</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The syndromic approach to managing STIs/RTIs particularly in settings with limited diagnostic capacity, involves treating the most common causative agents based on the presenting symptoms. For urethral discharge, the treatment needs to cover both gonococcal and non-gonococcal urethritis. The combination of <strong>Azithromycin</strong> and <strong>Cefixime</strong> is recommended because Azithromycin is effective against Chlamydia trachomatis, while Cefixime is effective against Neisseria gonorrhoeae. This combination provides broad coverage, addressing the most common bacterial causes of urethritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Azithromycin and Doxycycline</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">While Azithromycin covers non-gonococcal causes like Chlamydia, Doxycycline is also effective against Chlamydia but does not adequately cover gonococcal infections. Therefore, it is not the best choice for treating gonococcal urethritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. Cefixime and Metronidazole</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Cefixime is effective against gonorrhea; however, Metronidazole is primarily used for anaerobic infections and trichomoniasis and does not cover non-gonococcal urethritis effectively. This combination would miss Chlamydia, a common cause of urethritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Penicillin and Fluconazole</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Penicillin has limited efficacy against modern strains of gonorrhea due to resistance, and Fluconazole is used for fungal infections such as candidiasis, which is not relevant in this case. This combination does not appropriately address the bacterial causes of urethritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The syndromic management of STIs/RTIs </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture4_qh1QDFc.jpg\" style=\"height:491px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">especially in resource-limited settings, involves the use of broad-spectrum treatment targeting the most likely pathogens. For urethral discharge, the combination of Azithromycin and Cefixime covers both gonococcal and non-gonococcal infections, ensuring comprehensive care without specific pathogen identification.</span></span></span></p>",
      "correct_choice_id": 238479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9825,
      "choices": [
        {
          "id": 39267,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-5</span></p>"
        },
        {
          "id": 39268,
          "text": "<p><span style=\"font-size:12.0pt;\">INF-gamma</span></p>"
        },
        {
          "id": 39269,
          "text": "<p><span style=\"font-size:12.0pt;\">TNF-alpha</span></p>"
        },
        {
          "id": 39270,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Basophils are activated by? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5631039",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147736,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IL-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best answer for basophil differentiation of basophil is <strong>IL3 h</strong>owever considering the options given for this particular question in INICET exam the appropriate answer shall be IL-5</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Interleukin-5 (IL-5) is a cytokine that specifically acts on eosinophils and basophils. It plays a crucial role in their growth, differentiation, activation, and survival. In the case of basophils, IL-5 stimulates their activation, leading to the release of histamine and other mediators that are involved in allergic responses and inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IL-5: Primarily activates eosinophilia but also involved in basophil growth and differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. INF-gamma</strong>: Interferon-gamma is primarily involved in the activation of macrophages and is a key cytokine in the Th1 immune response, but it does not specifically activate basophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. TNF-alpha</strong>: Tumor Necrosis Factor-alpha is a pro-inflammatory cytokine involved in systemic inflammation and is a major mediator in the acute phase reaction, but it does not specifically activate basophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. IL-2</strong>: Interleukin-2 is crucial for the growth, proliferation, and differentiation of T cells and natural killer (NK) cells, but it does not play a significant role in the activation of basophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Interleukins are a type of cytokine, which are small proteins produced by immune cells that play a crucial role in regulating the immune response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A brief overview of some of the key interleukins and their functions:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-1 (IL-1):</strong> This interleukin is involved in the regulation of inflammation and immune responses, as well as activation of immune cells such as T cells and B cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-2 (IL-2):</strong> This cytokine is primarily produced by T cells and plays a key role in the activation and proliferation of T cells and natural killer (NK) cells. It is also involved in the differentiation of immune cells, such as the development of memory T cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-4 (IL-4):</strong> Plays a key role in the development of Th2 cells, which are involved in the immune response to parasites and allergies. IL-4 also stimulates the production of antibodies by B cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-5 (IL-5): </strong>Primarily activates eosinophils but also involved in basophil growth and differentiation,&nbsp;contributing to their role in allergic responses and inflammation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-6 (IL-6):</strong> Plays a key role in the regulation of inflammation and immune responses. It can stimulate the production of acute-phase proteins, such as C-reactive protein, as well as the activation of immune cells like plasma cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-10 (IL-10)</strong>: Plays a key role in regulating the immune response and limiting inflammation. It can suppress the production of pro-inflammatory cytokines, as well as the activation of immune cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-12 (IL-12</strong>): IL-12<strong>&nbsp;</strong>is involved in the activation of T cells and NK cells. It can stimulate the differentiation of Th1 cells, which are involved in the immune response to intracellular pathogens.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Wintrobe’s Clinical hematology, 14th edition</strong></span></p>",
      "correct_choice_id": 39267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9916,
      "choices": [
        {
          "id": 39630,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
        },
        {
          "id": 39631,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
        },
        {
          "id": 39632,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
        },
        {
          "id": 39633,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">3, 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A patient with cervical lymphadenopathy has (11;14) positive. Which of the following markers should be done to confirm the diagnosis? (</span></span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS </span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">NOV 2020)</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD10; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD 200; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">SOX11; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Cyclin D1</span></span></span></li>\r\n</ol>",
      "unique_key": "Q2608339",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147737,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) 3, 4</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">t (11;14) creating CyclinD1-IgH fusion gene is seen in mantle cell lymphoma has its origin from naive B cell. </span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Mantle cell lymphoma:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Uncommon lymphoid neoplasm that makes up about 8% of all NHL</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Usually presents in the fifth to sixth decades of life</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Male</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> predominance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Tumor cells closely resemble the normal mantle zone B cells that surround germinal centers</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">More indolent, <strong>SOX11 variant</strong> that often presents with circulating disease with splenomegaly but without significant lymphadenopathy and with a low Ki67 (&lt;10%).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Features:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Painless lymphadenopathy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Splenomegaly</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Multifocal mucosal involvement of small bowel and colon - lymphomatoid polyposis</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Histology:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/1116.jpg\" style=\"height:170px; width:574px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-180835.png\" style=\"height:290px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Immunophenotyping:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">High levels of <strong>cyclin D1</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD19, CD20</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Moderately high levels of surface Ig (usually IgM and IgD with &kappa; or &gamma; light chain)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD5+ and CD23-,</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> which helps to distinguish it from CLL/SLL. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The IgH genes lack somatic hypermutation, supporting an origin from a naive B cell.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CD10 (1):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CD10 is a marker commonly associated with follicular lymphoma and acute lymphoblastic leukemia, not mantle cell lymphoma.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CD200 (2):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CD200 is expressed in chronic lymphocytic leukemia (CLL) and other B-cell lymphomas but is not a primary marker for mantle cell lymphoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a patient with <strong>t(11;14)</strong> translocation, confirming the diagnosis of mantle cell lymphoma requires testing for <strong>Cyclin D1</strong> and <strong>SOX11</strong> expression.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1132-1133</span></strong></span></span></p>",
      "correct_choice_id": 39633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16148,
      "choices": [
        {
          "id": 64552,
          "text": "<p><span style=\"font-size:12pt;\">Partial nephrectomy</span></p>"
        },
        {
          "id": 64553,
          "text": "<p><span style=\"font-size:12pt;\">Partial nephrectomy + neoadjuvant chemotherapy</span></p>"
        },
        {
          "id": 64554,
          "text": "<p><span style=\"font-size:12pt;\">Radical nephrectomy</span></p>"
        },
        {
          "id": 64555,
          "text": "<p><span style=\"font-size:12pt;\">Radical nephrectomy + postoperative radiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 56-year-old male recently diagnosed with renal cell carcinoma, with imaging indicating a tumor size less than 4 cm, what would be the most suitable initial treatment approach for this patient's condition among the following options? (NEET PG 2020)</span></p>",
      "unique_key": "Q4002706",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147738,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Partial nephrectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For tumors less than 4 cm, the recommended procedure is a partial nephrectomy, also known as nephron-sparing surgery.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This procedure involves removing the tumor and a small margin of healthy tissue surrounding it while leaving the remainder of the kidney intact. It is the recommended treatment for smaller renal tumors, typically less than 4 cm in diameter (Stage T1a tumors). For the 56-year-old patient with a renal tumor less than 4 cm, partial nephrectomy is the preferred initial treatment approach as it aims to treat the cancer while preserving as much kidney function as possible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Partial nephrectomy + neoadjuvant chemotherapy: </strong>Renal cell carcinoma (RCC) is generally resistant to chemotherapy, making this option less relevant for the patient's situation given the size of the tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Radical nephrectomy: </strong>This procedure involves the removal of the entire affected kidney, the adrenal gland above the kidney, surrounding fatty tissue, and sometimes nearby lymph nodes. It is the preferred treatment for larger tumors or those that have started to spread outside the kidney. For a tumor less than 4 cm, and with no indication of it having spread, a radical nephrectomy may be more aggressive than necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Radical nephrectomy + postoperative radiotherapy: </strong>Renal cell carcinomas are resistant to radiotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Partial nephrectomy is the recommended initial treatment for renal cell carcinoma tumors less than 4 cm in diameter (Stage T1a), as it aims to remove the tumor while preserving as much kidney function as possible. This approach balances oncological control with the preservation of renal function.</span></p>",
      "correct_choice_id": 64552,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23242,
      "choices": [
        {
          "id": 92932,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-c, 3-d, 4-b</span></p>"
        },
        {
          "id": 92933,
          "text": "<p><span style=\"font-size:12.0pt;\">1-e, 2-c, 3-d, 4-b</span></p>"
        },
        {
          "id": 92934,
          "text": "<p><span style=\"font-size:12.0pt;\">1-e, 2-d, 3-c, 4-b</span></p>"
        },
        {
          "id": 92935,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-d, 3-c, 4-b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the wood lamp findings with the respective diseases:&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-181740.png\" alt=\"\" width=\"700\" height=\"290\"></p>",
      "unique_key": "Q6904619",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147739,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1-e,2-c,3-d,4-b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Erythrasma (1-e):&nbsp;</strong>Shows a characteristic coral red fluorescence under Wood's lamp. This fluorescence is due to the production of porphyrins by Corynebacterium minutissimum, the bacteria responsible for erythrasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pityriasis versicolor (2-c):&nbsp;</strong>Typically displays a&nbsp;<strong>yellow fluorescence</strong>. The causative yeast, Malassezia, can produce metabolites that fluoresce under a Wood's lamp.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tinea Capitis (3-d):&nbsp;</strong>Often shows a&nbsp;<strong>blue fluorescence</strong>. The fungi causing tinea capitis, like species of Microsporum, can fluoresce blue due to the presence of certain metabolic byproducts in the fungal cell walls.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Vitiligo (4-b):&nbsp;</strong>Exhibits a&nbsp;<strong>milky</strong> <strong>white fluorescence</strong>. This is because the areas affected by vitiligo lack melanin, making the skin appear distinctly brighter under the UV light of a Wood's lamp compared to normal skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-181843.png\" alt=\"\" width=\"500\" height=\"371\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/15/screenshot-2024-06-15-181948.png\" alt=\"\" width=\"700\" height=\"243\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wood's lamp is a useful diagnostic tool in dermatology for visualizing certain fungal and bacterial infections, as well as pigmentary disorders. The specific color of fluorescence can guide clinicians in making a preliminary diagnosis, which must be confirmed with additional tests or clinical evaluation.</span></p>",
      "correct_choice_id": 92933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14825,
      "choices": [
        {
          "id": 59261,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal humerus in children</span></p>"
        },
        {
          "id": 59262,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal radius</span></p>"
        },
        {
          "id": 59263,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal fibula</span></p>"
        },
        {
          "id": 59264,
          "text": "<p><span style=\"font-size:12.0pt;\">Distal femur</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:-4px;text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following childhood injuries will lead to a fish tail injury? (</span>INICET May 2020)</p>",
      "unique_key": "Q9760683",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147740,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Distal humerus in children</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Fishtail deformity&nbsp;</strong>of the distal humerus is a <strong>rare delayed complication</strong> of distal humeral fractures in children characterized by a contour abnormality of the distal&nbsp;humerus.</span></li><li><span style=\"font-size:12.0pt;\">It results from a non-developing or underdeveloped lateral trochlea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/10/42.jpg\" alt=\"\" width=\"250\" height=\"253\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It has been described after a variety of distal humeral fractures in early childhood, most commonly after supracondylar fractures, or lateral Condyle fractures.</span></li><li><span style=\"font-size:12.0pt;\">If identified in a young child, surgical closure of the medial and lateral portion of the physis may prevent the deformity from progressing and would not cause significant additional humeral length discrepancy.</span></li><li><span style=\"font-size:12.0pt;\">Whilst initially presumed to be a benign condition, long-term follow-up suggests that patients with&nbsp;<strong>fishtail deformity</strong>&nbsp;are prone to:</span><ul><li><span style=\"font-size:12.0pt;\">Functional impairment</span></li><li><span style=\"font-size:12.0pt;\">Ongoing pain</span></li><li><span style=\"font-size:12.0pt;\">Development of early osteoarthrosis</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Distal radius</strong>. Distal Radius Fractures are the most common site of pediatric forearm fractures and generally occur as a result of a fall on an outstretched hand with the wrist extended. Metaphyseal fractures can be at the volar apex (colle’s fracture) or dorsal apex (Smith’s fracture) or incomplete (torus/buckle fracture). Diaphyseal fracture may involve both bone fracture, plastic deformation or greenstick fracture. Fracture with dislocation includes monteggia and galeazzi fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/10/43.jpg\" alt=\"\" width=\"500\" height=\"271\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Distal femur.&nbsp;</strong>Distal femur fractures in children can have various fracture patterns, including supracondylar fractures, or fractures of any pattern from the Salter-Harris classification.&nbsp;&nbsp;Salter-Harris II fractures&nbsp;of the distal femur are the most common pattern in children. Even though distal femur fractures are relatively uncommon injuries, they can have significant implications for limb alignment and future growth. Distal femur fractures in children are typically related to trauma, such as falls, motor vehicle accidents, or contact sports. Patients have pain, swelling about the knee, deformity, and an inability to bear weight on the affected leg.&nbsp;Closed manipulation and casting is an option in displaced fractures, although they have significant potential for instability, which could lead to malunion.&nbsp;Internal fixation is the most commonly chosen treatments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fish tail deformity is a rare complication of distal humerus fracture in children.</span></p>",
      "correct_choice_id": 59261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59795,
      "choices": [
        {
          "id": 238481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Life expectancy at 1-year age, Infant mortality rate, and Literacy rate</span></span></span></p>"
        },
        {
          "id": 238482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Life expectancy at birth, Income, and Knowledge</span></span></span></p>"
        },
        {
          "id": 238483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Real GDP per capita, Health expenditure, and School enrolment ratio</span></span></span></p>"
        },
        {
          "id": 238484,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infant mortality rate, Gross National Income, and Education index</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">During a global health conference, a public health professional is discussing various measures used to assess the development and well-being of countries. She emphasizes the importance of understanding the components of widely recognized indices such as the Human Development Index (HDI). A medical student asks for clarification on what constitutes the HDI and its significance in comparing global health standards. Which of the following best describes the components that make up the Human Development Index?</span></span></span></p>",
      "unique_key": "Q8931076",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147741,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Life expectancy at birth, Income, and Knowledge</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The <strong>Human Development Index (HDI)</strong> is a composite measure used to assess the development status of countries by combining three main components: longevity (life expectancy at birth), income (measured by real GDP per capita in purchasing power parity, PPP, US$), and knowledge (mean years of schooling and literacy rate). This index provides a more comprehensive view of a country&#39;s development compared to economic measures alone, as it considers health, education, and income dimensions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Components Of HDI AND PQLI:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/03/picture5_mAoY8gc.jpg\" style=\"height:448px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Life expectancy at 1-year age, Infant mortality rate, and Literacy rate</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">This combination describes the components of the Physical Quality of Life Index (PQLI), not HDI. PQLI includes life expectancy at oneyear, infant mortality rate, and literacy rate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Real GDP per capita, Health expenditure, and School enrollment ratio</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">These indicators are related to economic and educational measures but do not encompass all three dimensions specifically used in the HDI calculation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Infant mortality rate, Gross National Income, and Education index</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">This combination includes related but incorrect components; infant mortality rate is not part of HDI, which focuses on life expectancy instead.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The Human Development Index (HDI) evaluates a country&#39;s overall development by incorporating health, education, and income metrics. HDI uses life expectancy at birth, GDP per capita adjusted for purchasing power, and education measures (mean years of schooling and literacy rate) to provide a broader view of human development beyond economic performance alone.</span></span></span></p>",
      "correct_choice_id": 238482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5197,
      "choices": [
        {
          "id": 20761,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 20762,
          "text": "<p><span style=\"font-size:12.0pt;\">Japanese encephalitis</span></p>"
        },
        {
          "id": 20763,
          "text": "<p><span style=\"font-size:12.0pt;\">Plague</span></p>"
        },
        {
          "id": 20764,
          "text": "<p><span style=\"font-size:12.0pt;\">Paragonimiasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organisms follow a bird-arthropod-human transmission route? (NEET PG 2019)</span></p>",
      "unique_key": "Q2367469",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147742,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Japanese encephalitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Japanese encephalitis follows bird-arthropod-human transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">JE virus infects several extra-human hosts, e.g., pigs and birds (like pond herons). The basic cycles of transmission are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(a) Pig → Mosquito → Pig</span></p><p><span style=\"font-size:12.0pt;\">(b) Bird → Mosquito → Bird</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Humans are incidental \"dead-end\" hosts</strong> and are infected by the bite of infected Culex mosquitoes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Malaria:</strong> Caused by Plasmodium parasites, transmitted by Anopheles mosquitoes, primarily involves a human-mosquito-human cycle without bird involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Plague:</strong> Caused by Yersinia pestis, typically involves rodents and fleas in its transmission cycle; humans are incidental hosts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paragonimiasis:</strong> Caused by Paragonimus worms, involves a cycle between snails, crabs/crayfish, and mammals (including humans), but not birds or typical arthropods like mosquitoes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The transmission cycles of diseases like Japanese encephalitis is crucial for implementing effective public health measures. In the case of JE, controlling mosquito populations and minimizing human exposure to mosquito bites, especially in areas where birds are present, are key strategies in preventing the disease.</span></p>",
      "correct_choice_id": 20762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16097,
      "choices": [
        {
          "id": 64348,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3</span></p>"
        },
        {
          "id": 64349,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3</span></p>"
        },
        {
          "id": 64350,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
        },
        {
          "id": 64351,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statements is true regarding the course of the mandibular nerve?&nbsp;</span>(INICET NOV 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Auriculotemporal nerve is a branch from the anterior division of the mandibular nerve, and it emerges from behind the temporomandibular joint.</span></li><li><span style=\"font-size:12.0pt;\">Buccal branch is a branch from the anterior division of the mandibular nerve, and it emerges from behind the mandibular ramus.</span></li><li><span style=\"font-size:12.0pt;\">Lingual nerve is a branch from the posterior division of the mandibular nerve, and it arcs around the submandibular duct.</span></li><li><span style=\"font-size:12.0pt;\">Ophthalmic nerve is a branch from the anterior division of the mandibular nerve, and it arises in the middle cranial fossa.</span></li></ol>",
      "unique_key": "Q2926970",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147863,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. 2,3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2</strong>: True. The buccal branch, which is indeed a branch of the anterior division of the mandibular nerve, emerges from behind the mandibular ramus. This nerve primarily supplies sensory innervation to the skin over the cheek and buccal mucosa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3:</strong> True. The lingual nerve, a branch from the posterior division of the mandibular nerve, is responsible for providing sensory innervation to the anterior two-thirds of the tongue. It famously arcs around the submandibular duct, a notable anatomical feature.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/16.jpg\" alt=\"\" width=\"500\" height=\"442\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1</strong>: Incorrect. The auriculotemporal nerve actually arises from the posterior division of the mandibular nerve, not the anterior division, and it does indeed emerge from behind the temporomandibular joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4:</strong> Incorrect. The ophthalmic nerve is not a branch of the mandibular nerve. Instead, it is an independent division of the trigeminal nerve (V1), originating from the trigeminal ganglion located in the middle cranial fossa. It is responsible for providing sensory innervation to the forehead, scalp, and parts of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The mandibular nerve's complex branching includes both sensory and motor components that are essential for facial sensation and movements. Understanding its branches, such as the buccal and lingual nerves, and their courses, is critical in dental, surgical, and diagnostic practices.</span></p>",
      "correct_choice_id": 64348,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10244,
      "choices": [
        {
          "id": 40942,
          "text": "<p><span style=\"font-size:18px;\">Candela</span></p>"
        },
        {
          "id": 40943,
          "text": "<p><span style=\"font-size:18px;\">Lux</span></p>"
        },
        {
          "id": 40944,
          "text": "<p><span style=\"font-size:18px;\">Lambert</span></p>"
        },
        {
          "id": 40945,
          "text": "<p><span style=\"font-size:18px;\">Lumen</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>What is the SI unit used to measure the brightness of light from a point source among the options provided? </strong><i><strong>[NEET PG 2021]</strong></i></span></p>",
      "unique_key": "Q3759355",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147864,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Candela</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The candela is the SI unit used to measure the brightness (luminous intensity) of a light source emitting light in a specific direction. It quantifies the amount of light emitted from a point source within a solid angle of one steradian.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>Lux: Usage:</strong> Measures illumination or illuminance.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Definition:</strong> It quantifies the amount of light reaching a surface. One lux is equal to one lumen per square meter.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>Lambert: Usage:</strong> Measures brightness or luminance.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Definition:</strong> It quantifies the amount of light emitted by a surface. One lambert is equal to the luminance of a surface emitting or reflecting one lumen per square centimeter.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>Lumen: Usage:</strong> Measures luminous flux.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Definition:</strong> It quantifies the total amount of visible light emitted by a source. One lumen is the luminous flux emitted within a solid angle of one steradian by a point source with a luminous intensity of one candela.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-143708.png\" alt=\"\" width=\"1000\" height=\"442\"></strong></span></p>",
      "correct_choice_id": 40942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11100,
      "choices": [
        {
          "id": 44366,
          "text": "<p><span style=\"font-size:18px;\">Diphtheria, Pertussis, Tetanus, HBV, Injectable Polio</span></p>"
        },
        {
          "id": 44367,
          "text": "<p><span style=\"font-size:18px;\">Diphtheria, Pertussis, Typhoid, HBV, Hib</span></p>"
        },
        {
          "id": 44368,
          "text": "<p><span style=\"font-size:18px;\">Diphtheria, Pertussis, Tetanus, Haemophilus influenza B, Pneumococcal vaccine</span></p>"
        },
        {
          "id": 44369,
          "text": "<p><span style=\"font-size:18px;\">Diphtheria, Tetanus, HBV, Haemophilus influenza B, Pertussis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A 2-month-old infant is brought to the pediatric clinic for her first round of vaccinations. The mother is anxious and wants to ensure her child receives all the necessary immunizations. You explain that one of the shots the child will receive is the Pentavalent vaccine, which combines five different immunizations into a single injection. Which of the following immunizations are combined in the Pentavalent vaccine? [</strong><i><strong>INICET MAY 2021]</strong></i></span></p>",
      "unique_key": "Q3232691",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147865,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Diphtheria, Tetanus, HBV, Haemophilus influenza B, Pertussis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Pentavalent vaccine consists of five vaccines - Diphtheria, Pertussis, Tetanus, Hepatitis B and Haemophilus Influenzae Type B (Hib).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture3777.jpg\" alt=\"\" width=\"200\" height=\"355\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>NEW National Immunization Schedule (NIS) 2023-24</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/screenshot-2023-10-27-190517.jpg\" alt=\"\" width=\"800\" height=\"380\"></strong></span></p>",
      "correct_choice_id": 44369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 574,
      "choices": [
        {
          "id": 2292,
          "text": "<p><span style=\"font-size:12pt;\">Halothane</span></p>"
        },
        {
          "id": 2293,
          "text": "<p><span style=\"font-size:12pt;\">Desflurane</span></p>"
        },
        {
          "id": 2294,
          "text": "<p><span style=\"font-size:12pt;\">Sevoflurane</span></p>"
        },
        {
          "id": 2295,
          "text": "<p><span style=\"font-size:12pt;\">Isoflurane</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following can be used for induction of anesthesia, maintenance and can be safely used in endotracheal intubation?</span></p>",
      "unique_key": "Q6487621",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147866,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Sevoflurane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sevoflurane is a versatile inhalation anesthetic that can be used for both the induction and maintenance of anesthesia. Its sweet smell makes it suitable for inhalational induction, especially in pediatric patients and others who might find pungent agents unpleasant. Sevoflurane also provides a smooth transition for endotracheal intubation due to its bronchodilatory effects and stable hemodynamic profile. Additionally, its low blood-gas solubility coefficient allows for rapid induction and emergence from anesthesia, which is beneficial in a surgical setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A. Halothane:</strong> While Halothane can be used for induction and maintenance of anesthesia, it has a higher risk of hepatotoxicity and arrhythmias. It is also less commonly used in modern practice compared to Sevoflurane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B. Desflurane:</strong> Desflurane is typically used for maintenance rather than induction due to its pungent odor and tendency to cause airway irritation. It also requires a special heated vaporizer due to its high vapor pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. Isoflurane</strong>: Isoflurane is primarily used for maintenance of anesthesia rather than induction due to its pungent smell and potential to cause airway irritation. It is less suitable for inhalational induction compared to Sevoflurane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sevoflurane is an ideal agent for both the induction and maintenance of anesthesia and is safe for use during endotracheal intubation due to its favorable properties.</span></p>",
      "correct_choice_id": 2294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11157,
      "choices": [
        {
          "id": 44594,
          "text": "<p><span style=\"font-size:18px;\">Kyasanur forest disease virus</span></p>"
        },
        {
          "id": 44595,
          "text": "<p><span style=\"font-size:18px;\">Orientia tsutsugamushi</span></p>"
        },
        {
          "id": 44596,
          "text": "<p><span style=\"font-size:18px;\">Chandipura virus</span></p>"
        },
        {
          "id": 44597,
          "text": "<p><span style=\"font-size:18px;\">Anaplasma phagocytophilia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A patient presents with flu-like symptoms after a camping trip and multiple insect bites. You suspect a vector-borne illness. Which pathogen is likely if the vector is a Trombiculid mite? </strong><i><strong>[AIIMS NOV 2019]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip42.jpg\" alt=\"\" width=\"300\" height=\"278\"></strong></span></p>",
      "unique_key": "Q6533170",
      "question_audio": null,
      "question_video": null,
      "map_id": 13147867,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Orientia tsutsugamushi</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Above given image depicts Trombiculid mite, which transmits Orientia tsutsugamushi. It causes scrub typhus disease in humans.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture5666.jpg\" alt=\"\" width=\"600\" height=\"663\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Life cycle of Trombiculid mite with transovarial transmission</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>Kyasanur forest disease virus:</strong> Kyasanur forest disease virus is transmitted by hard tick</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/image.png\" width=\"283\" height=\"292\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Chandipura virus:&nbsp;</strong>Chandipura virus is an Arbovirus transmitted by Sand fly (Phlebotomus)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture7666.jpg\" alt=\"\" width=\"300\" height=\"284\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Anaplasma phagocytophilia:&nbsp;</strong>Anaplasma phagocytophilia (formerly Ehrlichia phagocytophilum) is a Gram-negative bacterium that causes an acute febrile illness known as anaplasmosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Orientia tsutsugamushi, transmitted by Trombiculid mites, causes scrub typhus.</span></li></ul>",
      "correct_choice_id": 44595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54286,
      "choices": [
        {
          "id": 216613,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allergic Interstitial Nephritis</span></span></span></p>"
        },
        {
          "id": 216614,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pyelonephritis</span></span></span></p>"
        },
        {
          "id": 216615,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berger Disease</span></span></span></p>"
        },
        {
          "id": 216616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urinary Tract Infection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 10-year-old child presented with follicular tonsillitis, for which antibiotics were prescribed. In a few days, the child developed flank pain and rash. Peripheral blood demonstrated eosinophilia, and urinalysis showed WBC casts. What is the likely diagnosis?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3632140",
      "question_audio": null,
      "question_video": null,
      "map_id": 13444280,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A) Allergic Interstitial Nephritis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allergic interstitial nephritis (AIN), also known as drug-induced interstitial nephritis, is an immune-mediated condition commonly caused by medications such as antibiotics (e.g., penicillins). The clinical presentation of AIN typically includes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Recent medication use:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In this case, antibiotics for follicular tonsillitis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flank pain and rash:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These symptoms often develop a few days after starting the medication.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eosinophilia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Elevated levels of eosinophils in peripheral blood are a hallmark of allergic reactions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urinalysis findings:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Presence of white blood cell (WBC) casts in the urine indicates renal involvement.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The combination of these symptoms and laboratory findings strongly suggests allergic interstitial nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Pyelonephritis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pyelonephritis is characterized by fever, unilateral flank pain, and urinary symptoms like dysuria. It is usually associated with bacterial infection, not with recent antibiotic use or eosinophilia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Berger Disease (IgA Nephropathy):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> IgA nephropathy, or Berger disease, is a glomerulonephritis characterized by hematuria and sometimes proteinuria. It does not typically present with rash, eosinophilia, or WBC casts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Urinary Tract Infection (UTI):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A UTI would present with urinary symptoms such as dysuria, frequency, and urgency. It can also lead to pyelonephritis, but it does not typically cause eosinophilia or WBC casts in the absence of infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allergic interstitial nephritis is characterized by recent medication use (such as antibiotics), flank pain, rash, eosinophilia, and WBC casts in urine. It is an immune-mediated condition commonly caused by drugs, particularly antibiotics.</span></span></p>",
      "correct_choice_id": 216613,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}